FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Adriano Lazzarin

Research Profile

Disorders

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sabrina Bagaglio; Hamid Hasson; Adriano Lazzarin; Marco Merli; Emanuela Messina; Liviana Della Torre; Caterina Uberti-Foppa; Giulia Morsica
Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus.
Maria Rita Parisi; Stefano Rusconi; Karin Schlusnus; Laura Soldini; Gianmarino Vidoni; Teresa Belloni; Livia Brignolo; Felice Clemente; Fernanda Dorigatti; Chiara Mabellini; Silvia Negri; Silvia Nozza; Adriano Lazzarin
Cross-sectional study of community serostatus to highlight undiagnosed HIV infections with oral fluid HIV-1/2 rapid test in non-conventional settings.
Joseph J Eron; Tamio Fujiwara; Jenny Huang; Christine Katlama; Princy Kumar; Adriano Lazzarin; Sherene Min; Isabelle Poizot-Martin; Gary Richmond; Vincent Soriano; Cindy Vavro; Jane Yeo; Mounir Ait-Khaled; Bonaventura Clotet; Jacques Durant
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Adriano Lazzarin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sabrina Bagaglio; Hamid Hasson; Adriano Lazzarin; Marco Merli; Emanuela Messina; Liviana Della Torre; Caterina Uberti-Foppa; Giulia Morsica
Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus.
The Journal of antimicrobial chemotherapy 2013;68(6):1448-50.
2013: Maria Rita Parisi; Stefano Rusconi; Karin Schlusnus; Laura Soldini; Gianmarino Vidoni; Teresa Belloni; Livia Brignolo; Felice Clemente; Fernanda Dorigatti; Chiara Mabellini; Silvia Negri; Silvia Nozza; Adriano Lazzarin
Cross-sectional study of community serostatus to highlight undiagnosed HIV infections with oral fluid HIV-1/2 rapid test in non-conventional settings.
The new microbiologica 2013;36(2):121-32.
2013: Joseph J Eron; Tamio Fujiwara; Jenny Huang; Christine Katlama; Princy Kumar; Adriano Lazzarin; Sherene Min; Isabelle Poizot-Martin; Gary Richmond; Vincent Soriano; Cindy Vavro; Jane Yeo; Mounir Ait-Khaled; Bonaventura Clotet; Jacques Durant
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.
The Journal of infectious diseases 2013;207(5):740-8.
2013: Nicola Gianotti; Adriano Lazzarin; M Maillard; P Panzini; A Pazzi; Stefania Salpietro; D Zandonà; B Bocchiola; T Cahua; Anna Danise; Laura Galli; Antonella Castagna
Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
HIV medicine 2013;14(3):153-60.
2013: Pietro Vernazza; Cunshan Wang; Elizabeth Weil; Hernan Valdez; David A Cooper; Charles Craig; James Goodrich; Richard Kaplan; Adriano Lazzarin; Julie Mori; Anton Pozniak; Piotr Pulik; Margaret Tawadrous
Efficacy and safety of lersivirine (UK-453,061) versus efavirenz in antiretroviral treatment-naive HIV-1-infected patients: week 48 primary analysis results from an ongoing, multicenter, randomized, double-blind, phase IIb trial.
Journal of acquired immune deficiency syndromes (1999) 2013;62(2):171-9.
2013: Francesca Cossarini; Nicola Gianotti; Adriano Lazzarin; Vincenzo Spagnuolo; Alessia Carbone; Antonella Castagna
Management of HIV infection after triple class failure.
The new microbiologica 2013;36(1):23-39.
2012: Hamid Hasson; Adriano Lazzarin; Marco Merli; Giulia Morsica; Valentina Neri; Salvatore Sollima; Perluigi Blanc; Marco D'Annunzio; Laura Galli; Giulia Gallotta; Caterina Uberti-Foppa
HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study).
The new microbiologica 2012;35(4):469-74.
2012: Francesca Cossarini; Liviana Della Torre; Andrea Galli; Laura Galli; Nicola Gianotti; Adriano Lazzarin; Alba Bigoloni; Antonella Castagna; Stefania Salpietro; Vincenzo Spagnuolo; Concetta Vinci; Silvia Nozza
Immune recovery and T cell subset analysis during effective treatment with maraviroc.
The Journal of antimicrobial chemotherapy 2012;67(10):2474-8.
2012: Alba Bigoloni; Elisabetta Carini; Francesca Cossarini; Laura Galli; Nicola Gianotti; Adriano Lazzarin; Silvia Nozza; PierMarco Piatti; Stefania Salpietro; Vincenzo Spagnuolo; Concetta Vinci; Antonella Castagna
Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens.
AIDS (London, England) 2012;26(14):1837-40.
2012: Laura Galli; Alberto Galliani; Nicola Gianotti; Monica Guffanti; Hamid Hasson; Adriano Lazzarin; Gabriele Pellicciotta; PierMarco Piatti; Stefania Salpietro; Alba Bigoloni; Antonella Castagna
Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy.
European journal of epidemiology 2012;27(8):657-65.
2012: Edwin DeJesus; Mark J DiNubile; Adriano Lazzarin; Randi Leavitt; Jeffrey Lennox; Michael Miller; Bach-Yen Nguyen; Jürgen K Rockstroh; Anthony J Rodgers; Michael S Saag; Peter Sklar; Hedy Teppler; Monica L Walker; Hong Wan; Jing Zhao
Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK.
HIV clinical trials 2012;13(4):228-32.
2012: Massimo Andreoni; Andrea Antinori; Paola Cinque; Antonella d'Arminio Monforte; Giovanni Di Perri; Guerino Fares; Emanuela Foglia; Massimo Galli; Cristina Gervasoni; Giuseppe Ippolito; Adriano Lazzarin; Simone Marcotullio; Rita Murri; Silvia Nozza; Carlo Federico Perno; Giuliano Rizzardini; Stefano Rusconi
The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection.
The new microbiologica 2012;35(3):259-77.
2012: Francesca Cossarini; Laura Galli; Nicola Gianotti; Hamid Hasson; Adriano Lazzarin; Silvia Nozza; Stefania Salpietro; Vincenzo Spagnuolo; Giuseppe Tambussi; Simona Bossolasco; Antonella Castagna
Monotherapy with atazanavir as a simplification strategy: results from an observational study.
Journal of acquired immune deficiency syndromes (1999) 2012;60(3):e101-3.
2012: Vincenzo Spagnuolo; Giovanna Travi; Alba Bigoloni; Simona Bossolasco; Paola Cinque; Francesca Cossarini; Luca Fumagalli; Laura Galli; Nicola Gianotti; Monica Guffanti; Adriano Lazzarin; Stefania Salpietro; Antonella Castagna
Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.
International journal of cancer. Journal international du cancer 2012;130(12):2990-6.
2012: Andrea Antinori; Orlando Armignacco; Giampiero Carosi; Paola Cinque; Antonella d'Arminio Monforte; Giovanni Di Perri; Barbara Ensoli; Marco Floridia; Massimo Galli; Adriano Lazzarin; Simone Marcotullio; Claudio Mastroianni; Alberto Matteelli; Francesco Mazzotta; Mauro Moroni; Giorgio Pal; Massimo Puoti; Vincenzo Puro; Giuliano Rizzardini; evangelista sagnelli; Stefano Vella; Vincenzo Vullo; Adriana Ammassari; Massimo Andreoni; Gioacchino Angarano
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011.
The new microbiologica 2012;35(2):113-59.
2012: Giovanna Travi; Paola Cinque; Andrés J M Ferreri; Simonetta Gerevini; Adriano Lazzarin; Maurilio Ponzoni; Maria Rosa Terreni; Fulvio Crippa
Long-term remission of HIV-associated primary CNS lymphoma achieved with highly active antiretroviral therapy alone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(10):e119-21.
2012: Adriano Lazzarin; Soe Than; Srinivas R Valluri; Jayvant Heera; Geoffrey Mukwaya
Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access program.
HIV clinical trials 2012;13(2):83-9.
2012: Laura Galli; Nicola Gianotti; Adriano Lazzarin; Stefania Salpietro; Vincenzo Spagnuolo; Francesca Cossarini; Antonella Castagna
Mortality of HIV-infected patients with or without cancer: comparison with the general population in Italy.
Antiviral therapy 2012;17(3):447-58.
2011: Filippo Canducci; Antonella Castagna; Elisa R Ceresola; Francesca Cossarini; Adriano Lazzarin; Vincenzo Spagnuolo; Enzo Boeri; Massimo Clementi
Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir.
The Journal of infectious diseases 2011;204(11):1811-5.
2011: Jürgen K Rockstroh; Anthony Rodgers; Michael S Saag; Peter Sklar; Hedy Teppler; Monica L Walker; Hong Wan; Xia Xu; Jing Zhao; Edwin DeJesus; Mark J DiNubile; Adriano Lazzarin; Randi Leavitt; Jeffrey Lennox; Bach-Yen Nguyen
Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(8):807-16.
2011: Andrea Calcagno; Antonella Castagna; Antonio D'Avolio; Daniel Gonzalez de Requena; Adriano Lazzarin; Silvia Nozza; Stefano Bonora; Giovanni Di Perri
Pharmacokinetics of the raltegravir/maraviroc/etravirine combination.
The Journal of antimicrobial chemotherapy 2011;66(8):1932-4.
2011: Jean-Michel Molina; Laurence Rimsky; Michael Saag; Khuanchai Supparatpinyo; Simon Vanveggel; Sharon Walmsley; Katia Boven; Pedro Cahn; Herta Crauwels; Beatriz Grinsztejn; Adriano Lazzarin; Anthony Mills
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial.
Lancet 2011;378(9787):238-46.
2011: Leonid Gorelik; Carl Reid; Manuela Testa; Margot Brickelmaier; Simona Bossolasco; Annamaria Pazzi; Arabella Bestetti; Paul Carmillo; Ewa Wilson; Michele McAuliffe; Christopher Tonkin; John P Carulli; Alexey Lugovskoy; Adriano Lazzarin; Shamil Sunyaev; Kenneth Simon; Paola Cinque
Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity.
The Journal of infectious diseases 2011;204(1):103-14.
2011: Filippo Canducci; Antonella Castagna; E Ceresola; F Cossarin; Andrea Galli; Nicola Gianotti; Adriano Lazzarin; Silvia Nozza; Michela Sampaolo; V Spagnuolo; B Barda; Enzo Boeri; Massimo Clementi
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2011;17(6):928-34.
2011: Andrea Antinori; Giampiero Carosi; Paola Cinque; Antonella d'Arminio Monforte; Giovanni Di Perri; Barbara Ensoli; Enrico Ferrazzi; Massimo Galli; Adriano Lazzarin; Simone Marcotullio; Claudio Mastroianni; Alberto Matteelli; Francesco Mazzotta; Mauro Moroni; Giorgio Palù; Massimo Puoti; Vincenzo Puro; Giuliano Rizzardini; evangelista sagnelli; Fredy Suter; Stefano Vella; Adriana Ammassari; Massimo Andreoni; Gioacchino Angarano
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.
The new microbiologica 2011;34(2):109-46.
2011: Sabrina Bagaglio; G Bianchi; Anna Danise; L Porrino; Caterina Uberti-Foppa; Adriano Lazzarin; Antonella Castagna; Giulia Morsica
Longitudinal evaluation of occult hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption.
Infection 2011;39(2):121-6.
2011: Wendy P Bannister; Alessandro Cozzi-Lepri; Jesper Kjær; Bonaventura Clotet; Adriano Lazzarin; Jean-Paul Viard; Gitte Kronborg; Dan Duiculescu; Marek Beniowski; Ladislav Machala; Andrew Phillips
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy.
The Journal of antimicrobial chemotherapy 2011;66(4):901-11.
2011: Silvia Nozza; Laura Galli; Alba Bigoloni; Gianotti Nicola; Manuela Pogliaghi; Francesca Cossarini; Stefania Salpietro; Andrea Galli; Liviana Della Torre; Giuseppe Tambussi; Adriano Lazzarin; Antonella Castagna
Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: maraviroc, raltegravir, etravirine.
Journal of acquired immune deficiency syndromes (1999) 2011;56(4):e113-5.
2011: Francesca Cossarini; Enzo Boeri; Filippo Canducci; Stefania Salpietro; Alba Bigoloni; Laura Galli; Vincenzo Spagnuolo; Antonella Castagna; Massimo Clementi; Adriano Lazzarin; Nicola Gianotti
Integrase and fusion inhibitors transmitted drug resistance in naive patients with recent diagnosis of HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2011;56(2):e51-4.
2011: N Gianotti; F Visco; Laura Galli; B Barda; P Piatti; S Salpietro; Alba Bigoloni; C Vinci; Silvia Nozza; Giulia Gallotta; Adriano Lazzarin; Antonella Castagna
Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients.
HIV medicine 2011;12(2):109-17.
2011: Francesca Ferretti; Simonetta Gerevini; Monica Guffanti; Cristiana Iabichino; Adriano Lazzarin; Giuseppe Balconi; Antonio Boschini; Paola De Nardi; Paola Cinque
Disseminated Rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy.
BMC infectious diseases 2011;11():343.
2011: Valentina Svicher; Maurizio Zazzi; Jing Maria Zhang; Stefano Alcaro; Claudia Alteri; Massimo Andreoni; Andrea Antinori; Anna Artese; Francesca Ceccherini-Silberstein; Massimo Clementi; Giosuè Costa; Roberta D'Arrigo; Adriano Lazzarin; Fabio Mercurio; Giorgio Palu; Carlo Federico Perno
Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage.
Antiviral therapy 2011;16(7):1035-45.
2010: Marco Siccardi; Antonio D'Avolio; Silvia Nozza; Marco Simiele; Lorena Baietto; Francesca Romana Stefani; Darren Moss; Wai-San Kwan; Antonella Castagna; Adriano Lazzarin; Andrea Calcagno; Stefano Bonora; David Back; Giovanni Di Perri; Andrew Owen
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism.
Pharmacogenetics and genomics 2010;20(12):759-65.
2010: Hans-Jürgen Stellbrink; Chloe Orkin; Jose Ramon Arribas; Juliet Compston; Jan Gerstoft; Eric Van Wijngaerden; Adriano Lazzarin; Giuliano Rizzardini; Herman G Sprenger; John Lambert; Gunta Sture; David Leather; Sara Hughes; Patrizia Zucchi; Helen Pearce
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(8):963-72.
2010: Massimo Clementi; Adriano Lazzarin
Human immunodeficiency virus type 1 fitness and tropism: concept, quantification, and clinical relevance.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2010;16(10):1532-8.
2010: Sabrina Bagaglio; L Porrino; Adriano Lazzarin; Giulia Morsica
Molecular characterization of occult and overt hepatitis B (HBV) infection in an HIV-infected person with reactivation of HBV after antiretroviral treatment interruption.
Infection 2010;38(5):417-21.
2010: Jeffrey Lennox; Edwin Dejesus; Daniel S. Berger; Adriano Lazzarin; Richard B Pollard; Jose Valdez Ramalho Madruga; Jing Zhao; Hong Wan; Christopher L Gilbert; Hedy Teppler; Anthony Rodgers; Richard J O Barnard; Michael D Miller; Mark J DiNubile; Bach-Yen Nguyen; Randi Leavitt; Peter Sklar
Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses.
Journal of acquired immune deficiency syndromes (1999) 2010;55(1):39-48.
2010: Caterina Sagnelli; Caterina Uberti-Foppa; Laura Galli; Giuseppe Pasquale; Nicola Coppola; Luca Albarello; Addolorata Masiello; Carlo Doglioni; Adriano Lazzarin; evangelista sagnelli
Liver histology in HIV/hepatitis C-coinfected and HCV-monoinfected patients with persistently normal alanine aminotransferases.
Journal of acquired immune deficiency syndromes (1999) 2010;54(1):107-8.
2010: Chloe Orkin; Jianmin Wang; Colm Bergin; Jean-Michel Molina; Adriano Lazzarin; Matthias Cavassini; Stefan Esser; Juan Luis Gómez Sirvent; Helen Pearce
An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in Europe.
Pharmacogenetics and genomics 2010;20(5):307-14.
2010: Jose M Gatell; Christine Katlama; Beatriz Grinsztejn; Joseph J Eron; Adriano Lazzarin; Daniel Vittecoq; Charles J Gonzalez; Robert M Danovich; Hong Wan; Jing Zhao; Anne R Meibohm; Kim M Strohmaier; Charlotte M Harvey; Robin D Isaacs; Bach-Yen T Nguyen
Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study.
Journal of acquired immune deficiency syndromes (1999) 2010;53(4):456-63.
2010: Silvia Nozza; Laura Galli; Francesca Visco; Alessandro Soria; Filippo Canducci; Stefania Salpietro; Nicola Gianotti; Alba Bigoloni; Liviana Della Torre; Giuseppe Tambussi; Adriano Lazzarin; Antonella Castagna
Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience.
AIDS (London, England) 2010;24(6):924-8.
2010: Filippo Canducci; Maria Chiara Marinozzi; Michela Sampaolo; Enzo Boeri; Vincenzo Spagnuolo; Nicola Gianotti; Antonella Castagna; Stefania Paolucci; Fausto Baldanti; Adriano Lazzarin; Massimo Clementi
Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir.
The Journal of antimicrobial chemotherapy 2010;65(3):425-33.
2010: Alessandro Soria; Anna Danise; Laura Galli; Simon Tiberi; Elena Seminari; Francesca Cossarini; Alba Bigoloni; Simone Marcotullio; Adriano Lazzarin; Antonella Castagna
Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2010;47(3):253-7.
2010: Roy T Steigbigel; David A Cooper; Hedy Teppler; Joseph J Eron; Jose M Gatell; Princy N Kumar; Jurgen K Rockstroh; Mauro Schechter; Christine Katlama; Martin Markowitz; Patrick Yeni; Mona R Loutfy; Adriano Lazzarin; Jeffrey Lennox; Bonaventura Clotet; Jing Zhao; Hong Wan; Rand R Rhodes; Kim M Strohmaier; Richard J Barnard; Robin D Isaacs; Bach-Yen Nguyen
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(4):605-12.
2010: Paola Mantegani; Giuseppe Tambussi; Laura Galli; Chiara Tassan Din; Adriano Lazzarin; Claudio Fortis
Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset.
Immunology 2010;129(2):220-33.
2010: Jade Ghosn; Giampiero Carosi; Santiago Moreno; Vadim Pokrovsky; Adriano Lazzarin; Gilles Pialoux; Jose Sanz-Moreno; Agnes Balogh; Eric Vandeloise; Sophie Biguenet; Ghislaine Leleu; Jean-Francois Delfraissy
Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen.
Antiviral therapy 2010;15(7):993-1002.
2010: Antonella Castagna; Laura Galli; Carlo Torti; Antonella d'Arminio Monforte; Cristina Mussini; Andrea Antinori; Alessandro Cozzi-Lepri; Nicoletta Ladisa; Andrea De Luca; Elena Seminari; Nicola Gianotti; Adriano Lazzarin
Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.
Antiviral therapy 2010;15(2):165-75.
2009: Barbara Ensoli; Valeria Fiorelli; Fabrizio Ensoli; Adriano Lazzarin; Raffaele Visintini; Pasquale Narciso; Aldo Di Carlo; Antonella Tripiciano; Olimpia Longo; Stefania Bellino; Vittorio Francavilla; Giovanni Paniccia; Angela Arancio; Arianna Scoglio; Barbara Collacchi; Maria Jose Ruiz-Alvarez; Giuseppe Tambussi; Chiara Tassan Din; Guido Palamara; Alessandra Latini; Andrea Antinori; Gianpiero D'Offizi; Massimo Giuliani; Marina Giulianelli; Maria Carta; paolo monini; Mauro Magnani; Enrico Garaci
The preventive phase I trial with the HIV-1 Tat-based vaccine.
Vaccine 2009;28(2):371-8.
2009: Cristina Mussini; Giota Touloumi; Giorgos Bakoyannis; Caroline Sabin; Antonella Castagna; Laura Sighinolfi; Lars E Erikson; Goran Bratt; Vanni Borghi; Adriano Lazzarin; Andrea Cossarizza; Roberto Esposito
Magnitude and determinants of CD4 recovery after HAART resumption after 1 cycle of treatment interruption.
Journal of acquired immune deficiency syndromes (1999) 2009;52(5):588-94.
2009: F Cossarini; A Castagna; Adriano Lazzarin
Raltegravir in treatment naive patients.
European journal of medical research 2009;14 Suppl 3():22-9.
2009: Christine Katlama; Richard Haubrich; Jacob Lalezari; Adriano Lazzarin; José V Madruga; Jean-Michel Molina; Mauro Schechter; Monika Peeters; Gaston Picchio; Johan Vingerhoets; Brian Woodfall; Goedele De Smedt
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials.
AIDS (London, England) 2009;23(17):2289-300.
2009: Stefano Benedini; Gianluca Perseghin; Ileana Terruzzi; Paola Scifo; P L Invernizzi; Alessandro Del Maschio; Adriano Lazzarin; Livio Luzi
Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophy.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2009;41(11):840-5.
2009: Maria Rita Parisi; Laura Soldini; Giovanni Di Perri; Simon Tiberi; Adriano Lazzarin; Flavia B Lillo
Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programs.
The new microbiologica 2009;32(4):391-6.
2009: Jeffrey Lennox; Edwin DeJesus; Adriano Lazzarin; Richard B Pollard; Jose Valdez Ramalho Madruga; Daniel S. Berger; Jing Zhao; Xia Xu; Angela Williams-Diaz; Anthony Rodgers; Richard J O Barnard; Michael D Miller; Mark J DiNubile; Bach-Yen Nguyen; Randi Leavitt; Peter Sklar
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
Lancet 2009;374(9692):796-806.
2009: S Bellino; V Francavilla; O Longo; Antonella Tripiciano; G Paniccia; A Arancio; Valeria Fiorelli; Arianna Scoglio; Barbara Collacchi; M Campagna; Adriano Lazzarin; G Tambussi; C Tassan Din; R Visintini; Pasquale Narciso; A Antinori; Gianpiero D'Offizi; M Giulianelli; M Carta; Antonio Di Carlo; Guido Palamara; Massimo Giuliani; Maria Elena Laguardia; paolo monini; Mauro Magnani; Fabrizio Ensoli; Barbara Ensoli
Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate.
Reviews on recent clinical trials 2009;4(3):195-204.
2009: Robert L Murphy; Brigitte Autran; Christine Katlama; Gilles Brucker; Patrice Debre; Vincent Calvez; Bonaventura Clotet; Nathan Clumeck; Dominique Costagliola; Steven G Deeks; Lucy Dorrell; Jose Gatell; Ashley Haase; Michel Klein; Adriano Lazzarin; Andrew J McMichael; Laura Papagno; Timothy W Schacker; Simon Wain-Hobson; Bruce D Walker; Michael Youle
A step ahead on the HIV collaboratory.
Science (New York, N.Y.) 2009;324(5932):1264-5.
2009: Francesca Cossarini; Laura Galli; Caterina Sagnelli; Nicola Gianotti; Hamid Hasson; Massimo Clementi; Alessandro Soria; Stefania Salpietro; Adriano Lazzarin; Antonella Castagna
Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failure.
Journal of acquired immune deficiency syndromes (1999) 2009;51(2):179-84.
2009: Olimpia Longo; Antonella Tripiciano; Valeria Fiorelli; Stefania Bellino; Arianna Scoglio; Barbara Collacchi; Maria Josè Ruiz Alvarez; Vittorio Francavilla; Angela Arancio; Giovanni Paniccia; Adriano Lazzarin; Giuseppe Tambussi; Chiara Tassan Din; Raffaele Visintini; Pasquale Narciso; Andrea Antinori; Gianpiero D'Offizi; Marina Giulianelli; Maria Carta; Aldo Di Carlo; Guido Palamara; Massimo Giuliani; Maria Elena Laguardia; paolo monini; Mauro Magnani; Fabrizio Ensoli; Barbara Ensoli
Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up.
Vaccine 2009;27(25-26):3306-12.
2009: Giulia Morsica; Sabrina Bagaglio; Caterina Uberti-Foppa; Laura Galli; Adriano Lazzarin
Detection of hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in HIV/HCV-coinfected individuals treated with antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2009;51(1):106-8.
2009: Filippo Canducci; Michela Sampaolo; Maria Chiara Marinozzi; Enzo Boeri; Vincenzo Spagnuolo; Andrea Galli; Antonella Castagna; Adriano Lazzarin; Massimo Clementi; Nicola Gianotti
Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies.
AIDS (London, England) 2009;23(4):455-60.
2009: Vincenzo Spagnuolo; Nicola Gianotti; Elena Seminari; Laura Galli; Giuliana Fusetti; Stefania Salpietro; Adriano Lazzarin; Antonella Castagna
Changes in darunavir/r resistance score after previous failure to tipranavir/r in HIV-1-infected multidrug-resistant patients.
Journal of acquired immune deficiency syndromes (1999) 2009;50(2):192-5.
2009: Alessandro Soria; Klaudia Porten; Jean-Calvin Fampou-Toundji; Laura Galli; Rose Mougnutou; Vincent Buard; Anfumbom Kfutwah; Aurelia Vessière; Dominique Rousset; Roger Teck; Alexandra Calmy; Laura Ciaffi; Adriano Lazzarin; Nicola Gianotti
Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
Antiviral therapy 2009;14(3):339-47.
2009: Viviana Cremasco; Barbara Mantelli; Adriano Lazzarin; Priscilla Biswas
Improvement of CXCR3 ligand CXCL11/I-TAC measurement in human plasma and serum.
The new microbiologica 2009;32(1):125-8.
2008: Cristina Mussini; Christian Manzardo; Margaret Johnson; Antonella d'Arminio Monforte; Caterina Uberti-Foppa; Andrea Antinori; M John Gill; Laura Sighinolfi; Vanni Borghi; Adriano Lazzarin; José M Miró; Caroline Sabin
Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
AIDS (London, England) 2008;22(18):2461-9.
2008: Monica Guffanti; Giovanni Gaiera; Simona Bossolasco; Norberto Ceserani; Deborah Ratti; Paola Cinque; Flavia Salmaso; Nicola Gianotti; Adriano Lazzarin
Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.
The American journal of tropical medicine and hygiene 2008;79(5):715-8.
2008: Manlio Ferrarini; Fanny Delfanti; Monica Gianolini; Chiara Rizzi; Massimo Alfano; Adriano Lazzarin; Priscilla Biswas
NF-kappa B modulates sensitivity to apoptosis, proinflammatory and migratory potential in short- versus long-term cultured human gamma delta lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(9):5857-64.
2008: Barbara Ensoli; Valeria Fiorelli; Fabrizio Ensoli; Adriano Lazzarin; Raffaele Visintini; Pasquale Narciso; Aldo Di Carlo; paolo monini; Mauro Magnani; Enrico Garaci
The therapeutic phase I trial of the recombinant native HIV-1 Tat protein.
AIDS (London, England) 2008;22(16):2207-9.
2008: Alessandro Cozzi-Lepri; Andrew N Phillips; Bonaventura Clotet; Amanda Mocroft; Lidia Ruiz; Ole Kirk; Adriano Lazzarin; Alicja Wiercinska-Drapalo; Anders Karlsson; Jens D Lundgren
Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
AIDS (London, England) 2008;22(16):2187-98.
2008: Gerd Fätkenheuer; Mark Nelson; Adriano Lazzarin; Irina Konourina; Andy I M Hoepelman; Harry Lampiris; Bernard Hirschel; Pablo Tebas; François Raffi; Benoit Trottier; Nicholaos Bellos; Michael Saag; David A Cooper; Mike Westby; Margaret Tawadrous; John F Sullivan; Caroline Ridgway; Michael W Dunne; Steve Felstead; Howard Mayer; Elna van der Ryst
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
The New England journal of medicine 2008;359(14):1442-55.
2008: Annalisa Saracino; Nicola Gianotti; Marianna Marangi; Donatella Concetta Cibelli; Andrea Galli; Grazia Punzi; Laura Monno; Adriano Lazzarin; Gioacchino Angarano
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Journal of medical virology 2008;80(10):1695-706.
2008: Daniel Gonzalez de Requena; Stefano Bonora; Antonella Castagna; Hamid Hasson; Diego Aguilar Marucco; Antonio D'Avolio; Mauro Sciandra; Laura Trentini; Andrea Calcagno; Adriano Lazzarin; Giovanni Di Perri
Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.
The Journal of antimicrobial chemotherapy 2008;62(2):384-7.
2008: David A Cooper; Roy T Steigbigel; Jose M Gatell; Jurgen K Rockstroh; Christine Katlama; Patrick Yeni; Adriano Lazzarin; Bonaventura Clotet; Princy N Kumar; Joseph E Eron; Mauro Schechter; Martin Markowitz; Mona R Loutfy; Jeffrey Lennox; Jing Zhao; Joshua Chen; Desmond M Ryan; Rand R Rhodes; John A Killar; Lucinda R Gilde; Kim M Strohmaier; Anne R Meibohm; Michael D Miller; Daria J Hazuda; Michael L Nessly; Mark J DiNubile; Robin D Isaacs; Hedy Teppler; Bach-Yen Nguyen
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.
The New England journal of medicine 2008;359(4):355-65.
2008: Roy T Steigbigel; David A Cooper; Princy N Kumar; Joseph E Eron; Mauro Schechter; Martin Markowitz; Mona R Loutfy; Jeffrey Lennox; Jose M Gatell; Jurgen K Rockstroh; Christine Katlama; Patrick Yeni; Adriano Lazzarin; Bonaventura Clotet; Jing Zhao; Joshua Chen; Desmond M Ryan; Rand R Rhodes; John A Killar; Lucinda R Gilde; Kim M Strohmaier; Anne R Meibohm; Michael D Miller; Daria J Hazuda; Michael L Nessly; Mark J DiNubile; Robin D Isaacs; Bach-Yen Nguyen; Hedy Teppler
Raltegravir with optimized background therapy for resistant HIV-1 infection.
The New England journal of medicine 2008;359(4):339-54.
2008: Nicola Gianotti; Myriam Maillard; Giovanni Gaiera; Arabella Bestetti; Massimo Cernuschi; Anna de Bona; Adriano Lazzarin; Paola Cinque; Simona Bossolasco
Leishmania infection can hamper immune recovery in virologically suppressed HIV-infected patients.
The new microbiologica 2008;31(3):435-8.
2008: Wendy P Bannister; Alessandro Cozzi-Lepri; Bonaventura Clotet; Amanda Mocroft; Jesper Kjaer; Peter Reiss; Viktor von Wyl; Adriano Lazzarin; Christine Katlama; Andrew N Phillips; Lidia Ruiz; Jens D Lundgren
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):324-33.
2008: Alessandro Soria; Mariangela Cavarelli; Stefania Sala; Anna Ida Alessandrini; Gabriella Scarlatti; Adriano Lazzarin; Antonella Castagna
Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutations.
Journal of medical virology 2008;80(6):937-41.
2008: Ombretta Turriziani; Nicola Gianotti; Francesca Falasca; Arianna Boni; Anna Rita Vestri; Alice Zoccoli; Adriano Lazzarin; Guido Antonelli
Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy.
Journal of medical virology 2008;80(5):766-71.
2008: Sharon L Walmsley; Christine Katlama; Adriano Lazzarin; Keikawus Arestéh; Gerald Pierone; Gary Blick; Margaret Johnson; Ulrich Meier; Thomas R MacGregor; Johnathan G Leith
Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51).
Journal of acquired immune deficiency syndromes (1999) 2008;47(4):429-40.
2008: Nicola Gianotti; Simon Tiberi; Stefano Menzo; Anna Danise; Enzo Boeri; Laura Galli; Massimo Clementi; Adriano Lazzarin; Antonella Castagna
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy.
Journal of medical virology 2008;80(2):201-8.
2008: Judith Currier; Adriano Lazzarin; Louis Sloan; Nathan Clumeck; Jihad Slims; Deb McCarty; Helen Steel; Jörg-Peter Kleim; Tab Bonny; Judith Millard
Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study.
Antiviral therapy 2008;13(2):297-306.
2008: Stefano Benedini; Ileana Terruzzi; Adriano Lazzarin; Livio Luzi
Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophy.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2008;22(2):101-12.
2008: Maria Mercedes Santoro; Ada Bertoli; Patrizia Lorenzini; Adriano Lazzarin; Roberto Esposito; Giampiero Carosi; Giovanni Di Perri; Gaetano Filice; Mauro Moroni; Giuliano Rizzardini; Pietro Caramello; Renato Maserati; Pasquale Narciso; Antonietta Cargnel; Andrea Antinori; Carlo Federico Perno
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study.
AIDS patient care and STDs 2008;22(1):7-16.
2007: Andrea Caumo; Monica Guffanti; Gianluca Perseghin; Laura Galli; Adriano Lazzarin; Livio Luzi; Antonella Castagna
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity.
AIDS (London, England) 2007;21(17):2366-7.
2007: Hamid Hasson; Barbara Mantelli; Priscilla Biswas; Mauro S Malnati; Nicola Gianotti; Annunciata Vecchi; Silvia Nozza; Massimo Cernuschi; Enzo Boeri; Mario Clerici; Adriano Lazzarin; Alberto Beretta
Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1.
Journal of medical virology 2007;79(11):1640-9.
2007: Priscilla Biswas; Andrea Galli; Laura Galli; Chiara Tassan Din; Annunciata Vecchi; Mauro S Malnati; Adriano Lazzarin; Giuseppe Tambussi
Does cyclosporin A affect CCR5 and CXCR4 expression in primary HIV-1-infected patients?
Cytometry. Part B, Clinical cytometry 2007;72(6):433-41.
2007: Priscilla Biswas; Annunciata Vecchi; Paola Mantegani; Barbara Mantelli; Claudio Fortis; Adriano Lazzarin
Immunomodulatory effects of bovine colostrum in human peripheral blood mononuclear cells.
The new microbiologica 2007;30(4):447-54.
2007: Elena Seminari; Anna de Bona; Gianluca Gentilini; Laura Galli; Giulia Schira; Nicola Gianotti; Caterina Uberti-Foppa; Armando Soldarini; Fernanda Dorigatti; Adriano Lazzarin; Antonella Castagna
Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment.
The Journal of antimicrobial chemotherapy 2007;60(4):831-6.
2007: Amanda Mocroft; bruno ledergerber; Kai Zilmer; Ole Kirk; Bernard Hirschel; Jean-Paul Viard; Peter Reiss; Patrick Francioli; Adriano Lazzarin; Ladislav Machala; Andrew N Phillips; Jens D Lundgren
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
AIDS (London, England) 2007;21(14):1867-75.
2007: Alessandro Soria; Adriano Lazzarin
Antiretroviral treatment strategies and immune reconstitution in treatment-naïve HIV-infected patients with advanced disease.
Journal of acquired immune deficiency syndromes (1999) 2007;46 Suppl 1():S19-30.
2007: Amanda Mocroft; Andrew N Phillips; José M Gatell; bruno ledergerber; Martin Fisher; Nathan Clumeck; Marcelo H Losso; Adriano Lazzarin; G Fatkenheuer; Jens D Lundgren
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
Lancet 2007;370(9585):407-13.
2007: Jacques Reynes; Keikawus Arastéh; Bonaventura Clotet; Calvin Cohen; David A Cooper; Jean-François Delfraissy; Joseph J Eron; Keith Henry; Christine Katlama; Daniel R Kuritzkes; Jacob P Lalezari; Joep Lange; Adriano Lazzarin; Julio S G Montaner; Mark Nelson; Mary O' Hearn; Hans-Jürgen Stellbrink; Benoit Trottier; Sharon L Walmsley; Neil E Buss; Ralph DeMasi; Jain Chung; Lucille Donatacci; Denise Guimaraes; Lucy Rowell; Adeline Valentine; Martin Wilkinson; Miklos Salgo
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.
AIDS patient care and STDs 2007;21(8):533-43.
2007: Bruno Hoen; David A Cooper; Fiona C Lampe; Luc Perrin; Nathan Clumeck; Andrew N Phillips; Li-Ean Goh; Stefan Lindback; Daniel Sereni; Brian Gazzard; Julio Montaner; Hans-Jurgen Stellbrink; Adriano Lazzarin; Diane Ponscarme; Shlomo Staszewski; Lars Mathiesen; Don Smith; Robert Finlayson; Rainer Weber; Laurence Wegmann; George Janossy; Sabine Kinloch-de-Loes
Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(3):381-90.
2007: Nicola Gianotti; Monica Guffanti; Laura Galli; Alberto Margonato; Giulia Chiaravalli; Alba Bigoloni; Adriano Lazzarin; Antonella Castagna
Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir.
AIDS (London, England) 2007;21(12):1648-51.
2007: Adriano Lazzarin; Thomas Campbell; Bonaventura Clotet; Margaret Johnson; Christine Katlama; Arend Moll; William Towner; Benoit Trottier; Monika Peeters; Johan Vingerhoets; Goedele de Smedt; Benny Baeten; Greet Beets; Rekha Sinha; Brian Woodfall
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.
Lancet 2007;370(9581):39-48.
2007: Paola Mantegani; Federica Piana; Laura Galli; Paolo Scarpellini; Luigi Codecasa; Adriano Lazzarin; Daniela Cirillo; Claudio Fortis
Comparison of a commercial and an in-house T cell-based assay for the diagnosis of Mycobacterium tuberculosis infection.
The new microbiologica 2007;30(3):291-4.
2007: Anna de Bona; Laura Galli; Giulia Gallotta; Aurelia Guzzo; Laura Alagna; Adriano Lazzarin; Caterina Uberti-Foppa
Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapy.
The new microbiologica 2007;30(3):259-64.
2007: Mark R Nelson; Christine Katlama; Julio S G Montaner; David A Cooper; Brian Gazzard; Bonaventura Clotet; Adriano Lazzarin; Knud Schewe; Joep Lange; Christina Wyatt; Sue Curtis; Shan-Shan Chen; Stephen Smith; Norbert Bischofberger; James F Rooney
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years.
AIDS (London, England) 2007;21(10):1273-81.
2007: Andrea Crotti; Marina Lusic; Rossella Lupo; Patricia M-J Lievens; Elio Liboi; Giulia Della Chiara; Marco Tinelli; Adriano Lazzarin; Bruce K Patterson; Mauro Giacca; Chiara Bovolenta; Guido Poli
Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression.
Blood 2007;109(12):5380-9.
2007: José M Gatell; Dominique Salmon-Ceron; Adriano Lazzarin; Eric Van Wijngaerden; Francisco Antunes; Clifford Leen; Andrzej Horban; Victoria Wirtz; Linda Odeshoo; Monique Van den Dungen; Claudia Gruber; Emilio Ledesma
Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(11):1484-92.
2007: Giulia Morsica; Sabrina Bagaglio; Silvia Ghezzi; Chiara Lodrini; Elisa Vicenzi; Elena Santagostino; Alessandro Gringeri; Marco Cusini; Guido Carminati; Giampaolo Bianchi; Laura Galli; Adriano Lazzarin; Guido Poli
Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;39(2):82-6.
2007: Simona Bossolasco; Silvia Nozza; Giovanni Gaiera; Arabella Bestetti; Adriano Lazzarin; Paola Cinque
Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2.
AIDS (London, England) 2007;21(9):1223-5.
2007: Priscilla Biswas; Giuseppe Tambussi; Adriano Lazzarin
Access denied? The status of co-receptor inhibition to counter HIV entry.
Expert opinion on pharmacotherapy 2007;8(7):923-33.
2007: Beatriz Grinsztejn; Bach-Yen Nguyen; Christine Katlama; José M Gatell; Adriano Lazzarin; Daniel Vittecoq; Charles J Gonzalez; Joshua Chen; Charlotte M Harvey; Robin D Isaacs
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial.
Lancet 2007;369(9569):1261-9.
2007: Bonaventura Clotet; Nicholas Bellos; Jean-Michel Molina; David Cooper; Jean-Christophe Goffard; Adriano Lazzarin; Andrej Wöhrmann; Christine Katlama; Timothy Wilkin; Richard Haubrich; Calvin Cohen; Charles Farthing; Dushyantha Jayaweera; Martin Markowitz; Peter Ruane; Sabrina Spinosa-Guzman; Eric Lefebvre
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.
Lancet 2007;369(9568):1169-78.
2007: Nicola Gianotti; Alessandro Soria; Adriano Lazzarin
Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a review.
The new microbiologica 2007;30(2):79-88.
2007: Monica Guffanti; Andrea Caumo; Laura Galli; Alba Bigoloni; Andrea Galli; Geneviéve Dagba; Anna Danise; Livio Luzi; Adriano Lazzarin; Antonella Castagna
Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects.
European journal of endocrinology / European Federation of Endocrine Societies 2007;156(4):503-9.
2007: Joseph C Gathe; Gerald Pierone; Peter J Piliero; Keikawus Arastéh; Rafael Rubio; Richard G Lalonde; David Cooper; Adriano Lazzarin; Veronika M Kohlbrenner; Catherine Dohnanyi; John Sabo; Douglas Mayers
Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type-1 infected patients.
AIDS research and human retroviruses 2007;23(2):216-23.
2007: Morgane Bomsel; Claudia Pastori; Daniela Tudor; Chiara Alberti; Severine Garcia; Davide Ferrari; Adriano Lazzarin; Lucia Lopalco
Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.
AIDS (London, England) 2007;21(1):13-22.
2006: Paola Mantegani; Federica Piana; Luigi Codecasa; Laura Galli; Paolo Scarpellini; Adriano Lazzarin; Daniela Cirillo; Claudio Fortis
Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection.
Clinical medicine & research 2006;4(4):266-72.
2006: Nicola Gianotti; Laura Galli; Anna Danise; Hamid Hasson; Enzo Boeri; Adriano Lazzarin; Antonella Castagna
Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir.
Journal of medical virology 2006;78(12):1537-41.
2006: Priscilla Biswas; Alessandro Cozzi-Lepri; Fanny Delfanti; Andrea Galli; Vincenzo Colangeli; Maria Cristina Moioli; Antonella Scarchilli; Nicola Abrescia; Gianmarco Vigevani; Antonella d'Arminio Monforte; Roberto Novati; Adriano Lazzarin
Significant link between sCD30 changes and HIV viremia in patients treated with HAART.
Journal of medical virology 2006;78(12):1513-9.
2006: Pedro Cahn; Jorge Villacian; Adriano Lazzarin; Christine Katlama; Beatriz Grinsztejn; Keikawus Arastéh; Paulo López; Nathan Clumeck; Jan Gerstoft; Nikolas Stavrianeas; Santiago Moreno; Francisco Antunes; Dietmar Neubacher; Douglas Mayers
Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(10):1347-56.
2006: Hamid Hasson; Priscilla Biswas; Laura Galli; Samuele E Burastero; Anna Danise; Alba Bigoloni; Elisabetta Carini; Massimo Locatelli; Annunciata Vecchi; Adriano Lazzarin; Antonella Castagna
Selective increase in serum IgE following enfuvirtide administration in HIV-1 infected multidrug resistant patients.
The new microbiologica 2006;29(4):223-30.
2006: Daria Podlekareva; Amanda Mocroft; Ulrik B Dragsted; bruno ledergerber; Marek Beniowski; Adriano Lazzarin; Jonathan Weber; Nathan Clumeck; Norbert Vetter; Andrew Phillips; Jens D Lundgren
Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study.
The Journal of infectious diseases 2006;194(5):633-41.
2006: Charles B Hicks; Pedro Cahn; David A Cooper; Sharon L Walmsley; Christine Katlama; Bonaventura Clotet; Adriano Lazzarin; Margaret A Johnson; Dietmar Neubacher; Douglas Mayers; Hernan Valdez
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials.
Lancet 2006;368(9534):466-75.
2006: Claudia Pastori; Barbara Weiser; Claudia Barassi; Caterina Uberti-Foppa; Silvia Ghezzi; Renato Longhi; Giliola Calori; Harold Burger; Kimdar S. Kemal; Guido Poli; Adriano Lazzarin; Lucia Lopalco
Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression.
Blood 2006;107(12):4825-33.
2006: Luigi Codecasa; Paola Mantegani; Laura Galli; Adriano Lazzarin; Paolo Scarpellini; Claudio Fortis
An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
Journal of clinical microbiology 2006;44(6):1944-50.
2006: Nicola Gianotti; Vincenzo Mondino; Maria Cristina Rossi; Elisabetta Chiesa; Ivano Mezzaroma; Nicoletta Ladisa; Giovanni Guaraldi; Carlo Torti; Pierluigi Tarquini; Paula Castelli; Aldo Di Carlo; Enzo Boeri; Wilco Keulen; Paula Mc Kenna; Adriano Lazzarin
Comparison of a rule-based algorithm with a phenotype-based algorithm for the interpretation of HIV genotypes in guiding salvage regimens in HIV-infected patients by a randomized clinical trial: the mutations and salvage study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(10):1470-80.
2006: Priscilla Biswas; Silvia Nozza; Gabriella Scarlatti; Adriano Lazzarin; Giuseppe Tambussi
Oral CCR5 inhibitors: will they make it through?
Expert opinion on investigational drugs 2006;15(5):451-64.
2006: Antonella Castagna; Anna Danise; Stefano Menzo; Laura Galli; Nicola Gianotti; Elisabetta Carini; Enzo Boeri; Andrea Galli; Massimo Cernuschi; Hamid Hasson; Massimo Clementi; Adriano Lazzarin
Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).
AIDS (London, England) 2006;20(6):795-803.
2006: Nicola Gianotti; Laura Galli; Enzo Boeri; Anna de Bona; Monica Guffanti; Anna Danise; Stefania Salpietro; Adriano Lazzarin; Antonella Castagna
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2006;41(4):447-52.
2006: Michael Giordano; Thomas Kelleher; Richard J Colonno; Adriano Lazzarin; Kathleen Squires
The effects of the Roche AMPLICOR HIV-1 MONITOR UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisons.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;35(4):420-5.
2006: Caterina Sagnelli; Luca Fumagalli; Anna Prigitano; Paolo Baccari; Patrizia Magnani; Adriano Lazzarin
Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
The Journal of antimicrobial chemotherapy 2006;57(4):796-8.
2006: Margaret Johnson; Beatriz Grinsztejn; Claudia Rodriguez; Jeffrey Coco; Edwin DeJesus; Adriano Lazzarin; Kenneth Lichtenstein; Victoria Wirtz; Anna Rightmire; Linda Odeshoo; Colin McLaren
96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures.
AIDS (London, England) 2006;20(5):711-8.
2006: Mike Youle; Schlomo Staszweski; Bonaventura Clotet; José Ramon Arribas; Anders Blaxhult; Giampiero Carosi; Edwin DeJesus; Gianni Di Perri; Vicente Estrada; Martin Fisher; Colin Kovacs; Ranjababu Kulasegaram; Adriano Lazzarin; Debbie Marriott; Leopoldo Muñoz; Jacques Reynes; Peter Shalit; Jihad Slim; Christos M Tsoukas; Anthony Vaccaro; José Vera
Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment-experienced, HIV-infected individuals: recent data and consensus recommendations.
HIV clinical trials 2006;7(2):86-96.
2006: Samuele E Burastero; Clara Paolucci; Daniela Breda; Armando Soldarini; Fernanda Dorigatti; Elisa Soprana; Hamid Hasson; Priscilla Biswas; Adriano Lazzarin; Antonella Castagna
Immunological basis for IgE hyper-production in enfuvirtide-treated HIV- positive patients.
Journal of clinical immunology 2006;26(2):168-76.
2006: Simona Bossolasco; Kerstin I Falk; Maurilio Ponzoni; Norberto Ceserani; Fulvio Crippa; Adriano Lazzarin; Annika Linde; Paola Cinque
Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(4):e21-5.
2006: Nicoletta Burighel; Silvia Ghezzi; Silvia Nozza; Paola Del Bianco; Adriano Lazzarin; Giuseppe Tambussi; Guido Poli; Anita De Rossi
Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy.
Haematologica 2006;91(2):244-7.
2006: Hamid Hasson; Silvia Nozza; Barbara Mantelli; Priscilla Biswas; Adriano Lazzarin; Alberto Beretta
A case of HIV-associated fever of unknown origin: deficit of IL-1beta antagonistic activity and resolution with monocyte-granulocyte apheresis.
AIDS (London, England) 2006;20(2):312-3.
2006: Giovanni Sitia; Anna de Bona; Sabrina Bagaglio; Laura Galli; Carlo T Paties; Caterina Uberti-Foppa; Luca G Guidotti; Adriano Lazzarin; Giulia Morsica
Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy.
Antiviral therapy 2006;11(3):385-9.
2006: Caterina Uberti-Foppa; Anna de Bona; Laura Galli; Giovanni Sitia; Giulia Gallotta; Caterina Sagnelli; Carlo T Paties; Adriano Lazzarin
Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels.
Journal of acquired immune deficiency syndromes (1999) 2006;41(1):63-7.
2005: Livio Luzi; Elena Meneghini; Silvia Oggionni; Giuseppe Tambussi; Lucia Piceni Sereni; Adriano Lazzarin
GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled study.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(6):781-9.
2005: Mark Nelson; Keikawus Arastéh; Bonaventura Clotet; David A Cooper; Keith Henry; Christine Katlama; Jacob P Lalezari; Adriano Lazzarin; Julio S G Montaner; Mary E O'Hearn; Peter J Piliero; Jacques Reynes; Benoit Trottier; Sharon L Walmsley; Calvin Cohen; Joseph J Eron; Daniel R Kuritzkes; Joep Lange; Hans-Jürgen Stellbrink; Jean-François Delfraissy; Neil E Buss; Lucille Donatacci; Cynthia Wat; Lynn Smiley; Martin Wilkinson; Adeline Valentine; Denise Guimaraes; Ralph DeMasi; Jain Chung; Miklos Salgo
Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials.
Journal of acquired immune deficiency syndromes (1999) 2005;40(4):404-12.
2005: Silva Barbesti; Laura Soldini; Guisline Carcelain; Angelique Guignet; Vittorio Colizzi; Barbara Mantelli; Alessandro Corvaglia; Thun Tran-Minh; Fernanda Dorigatti; Brigitte Autran; Adriano Lazzarin; Alberto Beretta
A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: implications for large scale monitoring of HIV-infected patients in resource-limited settings.
Cytometry. Part B, Clinical cytometry 2005;68(1):43-51.
2005: Nicola Gianotti; Laura Galli; Enzo Boeri; Myriam Maillard; Giuseppe Serra; Deborah Ratti; Giulia Gallotta; Daniela Vacchini; Ylenia Tremolada; Adriano Lazzarin; Massimo Clementi; Antonella Castagna
In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients.
The new microbiologica 2005;28(4):319-26.
2005: Nicola Gianotti; Adriano Lazzarin
Sequencing antiretroviral drugs for long-lasting suppression of HIV replication.
The new microbiologica 2005;28(4):281-97.
2005: Sabrina Bagaglio; Paola Cinque; Sara Racca; Rosa Pedale; Maria Antonietta Grasso; Adriano Lazzarin; Giulia Morsica
Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients.
AIDS (London, England) 2005;19 Suppl 3():S151-65.
2005: Elena Seminari; Gianluca Gentilini; Laura Galli; Hamid Hasson; Anna Danise; Elisabetta Carini; Fernanda Dorigatti; Armando Soldarini; Adriano Lazzarin; Antonella Castagna
Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients.
The Journal of antimicrobial chemotherapy 2005;56(4):790-2.
2005: Giulia Morsica; Silvana Tasca; Priscilla Biswas; A Galli; M Malnati; Carlo T Paties; M Marinelli; Sabrina Bagaglio; Adriano Lazzarin; Claudio Fortis
Natural killer-cell cytotoxicity in HIV-positive and HIV-negative patients with and without severe course of hepatitis B virus infection.
Scandinavian journal of immunology 2005;62(3):318-24.
2005: Elena Seminari; Monica Guffanti; Paola Villani; Nicola Gianotti; Maria Cusato; Giuliana Fusetti; Andrea Galli; Antonella Castagna; Mario Regazzi; Adriano Lazzarin
Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients.
European journal of clinical pharmacology 2005;61(7):545-9.
2005: Keikawus Arastéh; Nathan Clumeck; Anton Pozniak; Adriano Lazzarin; Sandra De Meyer; Heidi Muller; Monika Peeters; Alex Rinehart; Eric Lefebvre
TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trial.
AIDS (London, England) 2005;19(9):943-7.
2005: Nicola Gianotti; Elena Seminari; Adriano Lazzarin; Enzo Boeri; Massimo Clementi; Anna Danise; Stefania Salpietro; Giuliana Fusetti; Antonella Castagna
Redistribution of human immunodeficiency virus type 1 variants resistant to protease inhibitors after a protease inhibitor-sparing regimen.
AIDS research and human retroviruses 2005;21(6):545-54.
2005: Claudia Barassi; Elisa Soprana; Claudia Pastori; Renato Longhi; Emanuele Buratti; Flavia B Lillo; C Marenzi; Adriano Lazzarin; Antonio G Siccardi; Lucia Lopalco
Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.
Journal of virology 2005;79(11):6848-58.
2005: Elena Seminari; Antonella Castagna; Armando Soldarini; Laura Galli; Giuliana Fusetti; Fernanda Dorigatti; Hamid Hasson; Anna Danise; Monica Guffanti; Adriano Lazzarin; Alessandro Rubinacci
Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
HIV medicine 2005;6(3):145-50.
2005: Sabrina Bagaglio; Maria Stella De Mitri; S Lodrini; Carlo T Paties; Romina Cassini; G Bianchi; Mauro Bernardi; Adriano Lazzarin; Giulia Morsica
Mutations in the E2-PePHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma.
Journal of viral hepatitis 2005;12(3):243-50.
2005: Margaret Johnson; Beatriz Grinsztejn; Claudia Rodriguez; Jeffrey Coco; Edwin DeJesus; Adriano Lazzarin; Kenneth Lichtenstein; Anna Rightmire; Serap Sankoh; Richard Wilber
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
AIDS (London, England) 2005;19(7):685-94.
2005: Nicola Gianotti; Elena Seminari; Monica Guffanti; Enzo Boeri; Paola Villani; Mario Regazzi; Alba Bigoloni; Giulia Schira; Simon Tiberi; Giuliana Fusetti; Adriano Lazzarin; Antonella Castagna
Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir.
The new microbiologica 2005;28(2):119-25.
2005: Ombretta Turriziani; Ornella Butera; Nicola Gianotti; Saverio G Parisi; Romualdo Mazzi; Enrico Girardi; Giancarlo Iaiani; Laura Antonelli; Adriano Lazzarin; Guido Antonelli
Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients.
AIDS (London, England) 2005;19(5):473-9.
2005: John Hornberger; Jesse Green; Neil Wintfeld; Matthias Cavassini; Jürgen Rockstroh; Giovanni Giuliani; Claudio De Carli; Adriano Lazzarin
Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in Italy.
HIV clinical trials 2005;6(2):92-102.
2005: Adriano Lazzarin
Enfuvirtide: the first HIV fusion inhibitor.
Expert opinion on pharmacotherapy 2005;6(3):453-64.
2005: Simona Bossolasco; Giliola Calori; Francesca Moretti; Antonio Boschini; Davide Bertelli; Maurizio Mena; Simonetta Gerevini; Arabella Bestetti; Rosa Pedale; Serena Sala; Stefania Sala; Adriano Lazzarin; Paola Cinque
Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(5):738-44.
2005: Flavia B Lillo; Sara Lodini; Davide Ferrari; Carol Stayton; Gianluca Taccagni; Laura Galli; Adriano Lazzarin; Caterina Uberti-Foppa
Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(3):451-7.
2005: Lucia Lopalco; Claudia Barassi; Clara Paolucci; Daniela Breda; D Brunelli; Marie Nguyen; Janin Nouhin; Tram T Luong; Lien X Truong; Mario Clerici; Giliola Calori; Adriano Lazzarin; Gianfranco Pancino; Samuele E Burastero
Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin.
The Journal of general virology 2005;86(Pt 2):339-48.
2005: Margaret Johnson; Beatriz Grinsztejn; Claudia Rodriguez; Jeffrey Coco; Edwin DeJesus; Adriano Lazzarin; Kenneth Lichtenstein; Anna Rightmire; Serap Sankoh; Richard Wilber
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
AIDS (London, England) 2005;19(2):153-62.
2005: Antonella Castagna; Priscilla Biswas; Alberto Beretta; Adriano Lazzarin
The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development.
Drugs 2005;65(7):879-904.
2004: Nicolai Sidenius; Manuela Nebuloni; Serena Sala; Pietro Zerbi; Richard W Price; Magnus Gisslen; Lars Hagberg; Luca Vago; Adriano Lazzarin; Francesco Blasi; Paola Cinque
Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease.
Journal of neuroimmunology 2004;157(1-2):133-9.
2004: Nicola Gianotti; Elena Seminari; Giuliana Fusetti; Stefania Salpietro; Enzo Boeri; Andrea Galli; Adriano Lazzarin; Massimo Clementi; Antonella Castagna
Impact of a treatment including tenofovir plus didanosine on the selection of the 65R mutation in highly drug-experienced HIV-infected patients.
AIDS (London, England) 2004;18(16):2205-8.
2004: Luigi Buonaguro; Maria Tagliamonte; Maria Lina Tornesello; Elisabetta Pilotti; Claudio Casoli; Adriano Lazzarin; Giuseppe Tambussi; Massimo Ciccozzi; Giovanni Rezza; Franco M Buonaguro
Screening of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy.
Journal of acquired immune deficiency syndromes (1999) 2004;37(2):1295-306.
2004: Claudia Barassi; Adriano Lazzarin; Lucia Lopalco
CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects.
Blood 2004;104(7):2205-6.
2004: Stefano Menzo; Antonella Castagna; Alessia Monachetti; Hamid Hasson; Anna Danise; Elisabetta Carini; Patrizia Bagnarelli; Adriano Lazzarin; Massimo Clementi
Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment.
Antimicrobial agents and chemotherapy 2004;48(9):3253-9.
2004: Kathleen Squires; Adriano Lazzarin; José M Gatell; William G Powderly; Vadim Pokrovskiy; Jean-François Delfraissy; Joseph Jemsek; Antonio Rivero; Willy Rozenbaum; Shannon Schrader; Michael Sension; Asda Vibhagool; Alexandra Thiry; Michael Giordano
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.
Journal of acquired immune deficiency syndromes (1999) 2004;36(5):1011-9.
2004: Antonella Castagna; Nicola Gianotti; Laura Galli; Anna Danise; Hamid Hasson; Enzo Boeri; Richard Hoetelmans; David Nauwelaers; Adriano Lazzarin
The NIQ of lopinavir is predictive of a 48-week virological response in highly treatment-experienced HIV-1-infected subjects treated with a lopinavir/ritonavir-containing regimen.
Antiviral therapy 2004;9(4):537-43.
2004: Paolo Scarpellini; Silvana Tasca; Laura Galli; Alberto Beretta; Adriano Lazzarin; Claudio Fortis
Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection.
Journal of clinical microbiology 2004;42(8):3469-74.
2004: Francesca J Torriani; Maribel Rodriguez-Torres; Jürgen K Rockstroh; Eduardo Lissen; Juan Gonzalez-García; Adriano Lazzarin; Giampiero Carosi; Joseph Sasadeusz; Christine Katlama; Julio Montaner; Hoel Sette; Sharon Passe; Jean De Pamphilis; Frank Duff; Uschi Marion Schrenk; Douglas T Dieterich
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
The New England journal of medicine 2004;351(5):438-50.
2004: Pedro Cahn; José M Gatell; Kathleen Squires; Lisa D Percival; Peter J Piliero; Ian A Sanne; Sarah Shelton; Adriano Lazzarin; Linda Odeshoo; Thomas D Kelleher; Alexandra Thiry; Michael D Giordano; Stephen M Schnittman
Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2004;3(3):92-8.
2004: Ombretta Turriziani; Nicola Gianotti; Federica Bambacioni; Paolo Emilio Manconi; Adriano Lazzarin; Guido Antonelli
Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patients.
AIDS research and human retroviruses 2004;20(7):701-3.
2004: Filippo Canducci; Adriano Lazzarin; Massimo Clementi
GB virus C and survival in persons with HIV infection.
The New England journal of medicine 2004;350(25):2617-8; author reply 2617-8.
2004: Bonaventura Clotet; François Raffi; David Cooper; Jean-François Delfraissy; Adriano Lazzarin; Graeme Moyle; Jürgen Rockstroh; Vincent Soriano; Jonathan Schapiro
Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations.
AIDS (London, England) 2004;18(8):1137-46.
2004: Donato Torre; Filippo Speranza; Silvia Ghezzi; Silvia Nozza; Giuseppe Tambussi; Laura Soldini; Fernanda Dorigatti; Adriano Lazzarin; Roberto Tambini; Guido Poli
Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretrovirals.
HIV clinical trials 2004;5(3):146-51.
2004: Paola Cinque; Manuela Nebuloni; Maria Lisa Santovito; Richard W Price; Magnus Gisslen; Lars Hagberg; Arabella Bestetti; Gianluca Vago; Adriano Lazzarin; Francesco Blasi; Nicolai Sidenius
The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.
Annals of neurology 2004;55(5):687-94.
2004: Giulia Morsica; Raffaele Bruno; Sabrina Bagaglio; Maria Stella De Mitri; Pietro Andreone; Adriano Lazzarin
Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3a.
AIDS (London, England) 2004;18(7):1080-2.
2004: Adriano Lazzarin
The role of host immunity in the control of HIV infection: from theory to diagnostic and therapeutic intervention.
The new microbiologica 2004;27(2 Suppl 1):135-9.
2004: Claudia Barassi; C Marenzi; Claudia Pastori; Renato Longhi; Adriano Lazzarin; Lucia Lopalco
A new prospective against HIV infection: induction of murin CCR5-downregulating antibodies.
The new microbiologica 2004;27(2 Suppl 1):85-94.
2004: Stefano Menzo; Antonella Castagna; Alessia Monachetti; Hamid Hasson; Anna Danise; Elisabetta Carini; Patrizia Bagnarelli; Adriano Lazzarin; Massimo Clementi
Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment.
The new microbiologica 2004;27(2 Suppl 1):51-61.
2004: Hamid Hasson; Antonella Castagna; Massimo Clementi; Stefano Menzo; Anna Danise; Adriano Lazzarin
The introduction of the fusion inhibitors in the HAART-regimens.
The new microbiologica 2004;27(2 Suppl 1):11-6.
2004: Nicola Gianotti; Alessandro Soria; Laura Galli; Barbara Giudici; Giuliana Fusetti; Adriano Lazzarin; Enzo Boeri; Antonella Castagna
Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients: 24-week immunological outcome.
AIDS (London, England) 2004;18(5):821-3.
2004: Elisa Vicenzi; Filippo Canducci; Debora Pinna; Nicasio Mancini; Silvia Carletti; Adriano Lazzarin; Claudio Bordignon; Guido Poli; Massimo Clementi
Coronaviridae and SARS-associated coronavirus strain HSR1.
Emerging infectious diseases 2004;10(3):413-8.
2004: Cristina Mussini; Patrizio Pezzotti; José M Miró; Esteban Martinez; Juan Carlos Lopez Bernaldo de Quiros; Paola Cinque; Vanni Borghi; Andrea Bedini; Pere Domingo; Pedro Cahn; Philippe Bossi; Andrea De Luca; Antonella d'Arminio Monforte; Mark Nelson; Nneka Nwokolo; Silvia Helou; Ricardo Negroni; Gaia Jacchetti; Spinello Antinori; Adriano Lazzarin; Andrea Cossarizza; Roberto Esposito; Andrea Antinori; Judith A Aberg
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(4):565-71.
2004: Nicola Gianotti; Alessandro Soria; Laura Galli; Antonella Castagna; Massimo Cernuschi; Hamid Hasson; Adriano Lazzarin
Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.
Journal of medical virology 2004;72(2):181-6.
2004: Hamid Hasson; Nicola Gianotti; Anna Danise; Elena Seminari; Enzo Boeri; Silvia Nozza; Antonella Castagna; Adriano Lazzarin
Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients.
AIDS (London, England) 2004;18(1):123-7.
2004: Arabella Bestetti; Silvia Presi; Chiara Pierotti; Simona Bossolasco; Serena Sala; Sara Racca; Paola Carrera; Adriano Lazzarin; Paola Cinque
Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance.
Journal of neurovirology 2004;10 Suppl 1():52-7.
2004: Alessandro Soria; Nicola Gianotti; Massimo Cernuschi; Adriano Lazzarin
Once-daily saquinavir and ritonavir in treatment-experienced HIV-1-infected individuals.
The new microbiologica 2004;27(1):11-5.
2003: Monica Guffanti; Cleta Raffaella De Pascalis; Elena Seminari; Giuliana Fusetti; Nicola Gianotti; Dante Bassetti; Andrea Galli; Antonella Castagna; Adriano Lazzarin
Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients.
AIDS (London, England) 2003;17(18):2669-71.
2003: Enzo Boeri; Nicola Gianotti; Filippo Canducci; Hamid Hasson; Barbara Giudici; Antonella Castagna; Adriano Lazzarin; Massimo Clementi
Evolutionary characteristics of HIV type 1 variants resistant to protease inhibitors in the absence of drug-selective pressure.
AIDS research and human retroviruses 2003;19(12):1151-3.
2003: Priscilla Biswas; Barbara Mantelli; Hamid Hasson; Annunciata Vecchi; Abby R Saniabadi; Adriano Lazzarin; Alberto Beretta
In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disorders.
Clinical immunology (Orlando, Fla.) 2003;109(3):355-8.
2003: Silvana Tasca; Giuseppe Tambussi; Silvia Nozza; Brunella Capiluppi; Maria Raffaella Zocchi; Laura Soldini; Fabrizio Veglia; Guido Poli; Adriano Lazzarin; Claudio Fortis
Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis.
AIDS (London, England) 2003;17(16):2291-8.
2003: Simona Bossolasco; Giovanni Gaiera; Davide Olchini; Maurizio Gulletta; Leonardo Martello; Arabella Bestetti; Laura Bossi; Luca Germagnoli; Adriano Lazzarin; Caterina Uberti-Foppa; Paola Cinque
Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis.
Journal of clinical microbiology 2003;41(11):5080-4.
2003: Priscilla Biswas; Barbara Mantelli; Fanny Delfanti; Manlio Ferrarini; Guido Poli; Adriano Lazzarin
CD30 ligation differentially affects CXCR4-dependent HIV-1 replication and soluble CD30 secretion in non-Hodgkin cell lines and in gamma delta T lymphocytes.
European journal of immunology 2003;33(11):3136-45.
2003: Paolo Scarpellini; Paola Carrera; Paola Cichero; C Gelfi; Andrea Gori; M Ferrari; Anna Zingale; Adriano Lazzarin
Detection of resistance to isoniazid by denaturing gradient-gel electrophoresis DNA sequencing in Mycobacterium tuberculosis clinical isolates.
The new microbiologica 2003;26(4):345-51.
2003: Francesco Broccolo; Paolo Scarpellini; Giuseppe Locatelli; Anna Zingale; Anna M Brambilla; Paola Cichero; Leonardo A Sechi; Adriano Lazzarin; Paolo Lusso; Mauro S Malnati
Rapid diagnosis of mycobacterial infections and quantitation of Mycobacterium tuberculosis load by two real-time calibrated PCR assays.
Journal of clinical microbiology 2003;41(10):4565-72.
2003: Caterina Uberti-Foppa; Davide Ferrari; Sara Lodini; Salvatore Reina; Franco Ameglio; Maria Antonietta Grasso; Giulia Gallotta; Augusto Ferrari; Gianluca Taccagni; Adriano Lazzarin; Flavia B Lillo
Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women.
AIDS (London, England) 2003;17(14):2136-8.
2003: Anna Maria Brambilla; Roberto Novati; Giliola Calori; Elena Meneghini; Daniela Vacchini; Livio Luzi; Antonella Castagna; Adriano Lazzarin
Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals.
AIDS (London, England) 2003;17(13):1993-5.
2003: Massimo Galli; Fabrizio Veglia; Gioacchino Angarano; Sara Santambrogio; Elena Meneghini; Francesco Gritti; Antonietta Cargnel; Francesco Mazzotta; Adriano Lazzarin
Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns.
Journal of acquired immune deficiency syndromes (1999) 2003;34(1):58-61.
2003: Amanda Mocroft; Lidia Ruiz; Peter Reiss; bruno ledergerber; Christine Katlama; Adriano Lazzarin; Frank-Detlef Goebel; Andrew N Phillips; Bonaventura Clotet; Jens D Lundgren
Virological rebound after suppression on highly active antiretroviral therapy.
AIDS (London, England) 2003;17(12):1741-51.
2003: Simona Porcellini; Giuliana Vallanti; Silvia Nozza; Guido Poli; Adriano Lazzarin; Giuseppe Tambussi; Antonio G Siccardi; Fabio Grassi
Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration.
AIDS (London, England) 2003;17(11):1621-30.
2003: Caterina Uberti-Foppa; Anna de Bona; Giulia Morsica; Laura Galli; Giulia Gallotta; Enzo Boeri; Adriano Lazzarin
Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;33(2):146-52.
2003: Anna Zingale; Paola Carrera; Adriano Lazzarin; Paolo Scarpellini
Detection of Pneumocystis carinii and characterization of mutations associated with sulfa resistance in bronchoalveolar lavage samples from human immunodeficiency virus-infected subjects.
Journal of clinical microbiology 2003;41(6):2709-12.
2003: Priscilla Biswas; Barbara Mantelli; Antonio Sica; Mauro S Malnati; Carla Panzeri; Alessandra Saccani; Hamid Hasson; Annunciata Vecchi; Abby R Saniabadi; Paolo Lusso; Adriano Lazzarin; Alberto Beretta
Expression of CD4 on human peripheral blood neutrophils.
Blood 2003;101(11):4452-6.
2003: Adriano Lazzarin; Bonaventura Clotet; David Cooper; Jacques Reynes; Keikawus Arastéh; Mark Nelson; Christine Katlama; Hans-Jürgen Stellbrink; Jean-François Delfraissy; Joep Lange; Les Huson; Ralph DeMasi; Cynthia Wat; John Delehanty; Claude Drobnes; Miklos Salgo
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.
The New England journal of medicine 2003;348(22):2186-95.
2003: S Lodrini; Sabrina Bagaglio; Filippo Canducci; Maria Stella De Mitri; Pietro Andreone; Elisabetta Loggi; Adriano Lazzarin; M Clementi; Giulia Morsica
Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
Journal of biological regulators and homeostatic agents 2003;17(2):198-204.
2003: Anna de Bona; Giovanni Sitia; Caterina Uberti-Foppa; Laura Galli; Donatella Ciuffreda; Giulia Gallotta; Carlo T Paties; Adriano Lazzarin
Impact of HAART on liver histology of HIV/HCV coinfected patients.
Journal of biological regulators and homeostatic agents 2003;17(2):195-7.
2003: Filippo Canducci; Caterina Uberti-Foppa; Enzo Boeri; Sara Racca; Giulia Gallotta; Maria Antonietta Grasso; Giliola Calori; Adriano Lazzarin; Massimo Clementi
Characterization of GBV-C infection in HIV-1 infected patients.
Journal of biological regulators and homeostatic agents 2003;17(2):191-4.
2003: Sabrina Bagaglio; R Bruno; S Lodrini; Maria Stella De Mitri; Pietro Andreone; Elisabetta Loggi; Laura Galli; Adriano Lazzarin; Giulia Morsica
Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.
Journal of biological regulators and homeostatic agents 2003;17(2):153-61.
2003: Francesco Mazzotta; Sergio Lo Caputo; Carlo Torti; Carmine Tinelli; Piera Pierotti; Francesco Castelli; Adriano Lazzarin; Gioacchino Angarano; Renato Maserati; Nicola Gianotti; Nicoletta Ladisa; Eugenia Quiros-Roldan; Alex R Rinehart; Giampiero Carosi
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial.
Journal of acquired immune deficiency syndromes (1999) 2003;32(3):268-80.
2003: Livio Luzi; Gianluca Perseghin; Giuseppe Tambussi; Elena Meneghini; Paola Scifo; Emanuela Pagliato; Alessandro Del Maschio; Giulio Testolin; Adriano Lazzarin
Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy.
American journal of physiology. Endocrinology and metabolism 2003;284(2):E274-80.
2003: Pasquale Narciso; Adriano Lazzarin
Genotypic resistance tests for the clinical management of patients with primary HIV infection.
Scandinavian journal of infectious diseases. Supplementum 2003;106():66-70.
2003: Paola Cinque; Simona Bossolasco; Anna Maria Brambilla; Antonio Boschini; Cristina Mussini; Chiara Pierotti; Adriana Campi; Salvatore Casari; Davide Bertelli; Maurizio Mena; Adriano Lazzarin
The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature.
Journal of neurovirology 2003;9 Suppl 1():73-80.
2003: Priscilla Biswas; Manlio Ferrarini; Barbara Mantelli; Claudio Fortis; Guido Poli; Adriano Lazzarin; angelo manfredi
Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
European journal of immunology 2003;33(1):252-63.
2002: Paola Cinque; Simona Bossolasco; Arabella Bestetti; Serena Sala; Chiara Pierotti; Adriano Lazzarin
Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1-associated opportunistic central nervous system diseases--an update.
Journal of neurovirology 2002;8 Suppl 2():122-8.
2002: Francesco Broccolo; Simona Bossolasco; Anna M Careddu; Giuseppe Tambussi; Adriano Lazzarin; Paola Cinque
Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance.
Clinical and diagnostic laboratory immunology 2002;9(6):1222-8.
2002: Carlo Contini; Rosario Cultrera; Silva Seraceni; Daniela Segala; Roberto Romani; Enrico Fainardi; Paola Cinque; Adriano Lazzarin; Salvatore Delia
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS.
Journal of medical microbiology 2002;51(10):879-90.
2002: Simona Bossolasco; Paola Cinque; Maurilio Ponzoni; Maria Grazia Vigano; Adriano Lazzarin; Annika Linde; Kerstin I Falk
Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.
Journal of neurovirology 2002;8(5):432-8.
2002: Mauro S Malnati; Francesco Broccolo; Silvia Nozza; Loredana Sarmati; Silvia Ghezzi; Giuseppe Locatelli; Fanny Delfanti; Brunella Capiluppi; Anna M Careddu; Massimo Andreoni; paolo monini; Guido Poli; Adriano Lazzarin; Paolo Lusso; Giuseppe Tambussi
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy.
Blood 2002;100(5):1575-8.
2002: Alexandre Harari; G Paolo Rizzardi; Kim Ellefsen; Donatella Ciuffreda; Patrick Champagne; Pierre-Alexandre Bart; Daniel Kaufmann; Amalio Telenti; Roland Sahli; Giuseppe Tambussi; Laurent Kaiser; Adriano Lazzarin; Luc Perrin; Giuseppe Pantaleo
Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.
Blood 2002;100(4):1381-7.
2002: Roberto Novati; Maria Grazia Viganò; Anna de Bona; Benedetta Nocita; Renato Finazzi; Adriano Lazzarin
Neurobrucellosis with spinal cord abscess of the dorsal tract: a case report.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2002;6(2):149-50.
2002: Paolo Scarpellini; Paola Carrera; Annalisa Cavallero; Massimo Cernuschi; Gianni Mezzi; Pier Alberto Testoni; Anna Zingale; Adriano Lazzarin
Direct detection of Helicobacter pylori mutations associated with macrolide resistance in gastric biopsy material taken from human immunodeficiency virus-infected subjects.
Journal of clinical microbiology 2002;40(6):2234-7.
2002: Lucinda Furci; Lucia Lopalco; Patrizia Loverro; Marina Sinnone; Giuseppe Tambussi; Adriano Lazzarin; Paolo Lusso
Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals.
AIDS (London, England) 2002;16(7):1003-8.
2002: Claudio Fortis; Laura Soldini; Silvia Ghezzi; Stefania Colombo; Giuseppe Tambussi; Elisa Vicenzi; Nicola Gianotti; Silvia Nozza; Fabrizio Veglia; Michelangelo Murone; Adriano Lazzarin; Guido Poli
Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2.
AIDS research and human retroviruses 2002;18(7):491-9.
2002: Alberto Beretta; Hamid Hasson; Abby Samiabadi; Massimo Alfano; Daria Trabattoni; Flavia B Lillo; Pasquale Ferrante; Mario Clerici; Adriano Lazzarin
Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients: short-term and long-term effects on immunological and virological parameters.
Perfusion 2002;17 Suppl():47-51.
2002: Milos Opravil; Bernard Hirschel; Adriano Lazzarin; Hansjakob Furrer; Jean-Philippe Chave; Sabine Yerly; Leslie Bisset; Marek Fischer; Pietro Vernazza; Enos Bernasconi; Manuel Battegay; bruno ledergerber; Huldrych Günthard; Colin Howe; Rainer Weber; Luc Perrin
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection.
The Journal of infectious diseases 2002;185(9):1251-60.
2002: Francesca Moretti; Caterina Uberti-Foppa; Eugenia Quiros-Roldan; Lorella Fanti; Flavia B Lillo; Adriano Lazzarin
Oesophagobronchial fistula caused by varicella zoster virus in a patient with AIDS: a unique case.
Journal of clinical pathology 2002;55(5):397-8.
2002: Sabrina Bagaglio; Giovanni Sitia; D Prati; D Cella; Hamid Hasson; Roberto Novati; Adriano Lazzarin; Giulia Morsica
Mother-to-child transmission of TT virus: sequence analysis of non-coding region of TT virus in infected mother-infant pairs.
Archives of virology 2002;147(4):803-12.
2002: Antonella Castagna; Anna Danise; Barbara Giudici; Adriano Lazzarin; F Castelli; G Paraninfo; G Carosi; P L Carriero
Long-term response in patients receiving HAART including nelfinavir: experience from two Italian centers.
Journal of chemotherapy (Florence, Italy) 2002;14(2):189-93.
2002: G Paolo Rizzardi; Alexandre Harari; Brunella Capiluppi; Giuseppe Tambussi; Kim Ellefsen; Donatella Ciuffreda; Patrick Champagne; Pierre-Alexandre Bart; Jean-Philippe Chave; Adriano Lazzarin; Giuseppe Pantaleo
Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy.
The Journal of clinical investigation 2002;109(5):681-8.
2002: Claudia Pastori; Claudia Barassi; Flavia B Lillo; Renato Longhi; Brunella Capiluppi; Silvia Nozza; Andrea Galli; Caterina Uberti-Foppa; Adriano Lazzarin; Giuseppe Tambussi; Lucia Lopalco
The effect of HAART on humoral immune response in primary HIV-1 infected patients.
Journal of biological regulators and homeostatic agents 2002;16(1):9-17.
2002: Brunella Capiluppi; A Saracco; Nicola Gianotti; Cristina Mussini; L Butini; L Tomasoni; M De Gennaro; L Rizzolo; G Monolo; A Cargnel; C Moioli; C Arici; V Portelli; Giuliano Rizzardini; Adriano Lazzarin; Giuseppe Tambussi
Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.
Journal of biological regulators and homeostatic agents 2002;16(1):73-8.
2002: Hamid Hasson; Abby R Saniabadi; Massimo Alfano; Daria Trabattoni; Pasquale Ferrante; Flavia B Lillo; Mario Clerici; Adriano Lazzarin; Alberto Beretta
Granulocyte/monocyte apheresis induces sustained increases in CD4 T cells in HIV-1 infected patients with poor CD4 T cell restoration after suppression of viral replication by HAART.
Journal of biological regulators and homeostatic agents 2002;16(1):58-63.
2002: Flavia B Lillo; M Grasso; Sara Lodini; Brunella Capiluppi; Adriano Lazzarin; Giuseppe Tambussi
HIV-1 DNA and RNA kinetics in primary HIV infection.
Journal of biological regulators and homeostatic agents 2002;16(1):49-52.
2002: Luigi Buonaguro; Maria Tagliamonte; Maria Lina Tornesello; Donatella Ciuffreda; Brunella Capiluppi; Lucia Lopalco; Adriano Lazzarin; Giuseppe Tambussi; Franco M Buonaguro
Molecular and phylogenetic characterization of HIV variants in Italian primary HIV infections (PHI): identification of non-B subtype variants.
Journal of biological regulators and homeostatic agents 2002;16(1):44-8.
2002: Michela Violin; Federica Forbici; Alessandro Cozzi-Lepri; Rossella Velleca; Ada Bertoli; Chiara Riva; Sara Giannella; Paolo E Manconi; Adriano Lazzarin; S Pasquinucci; L Tacconi; Giuseppe Carnevale; Francesco Mazzotta; L Bonazzi; Maria Montroni; Antonio Chirianni; Maria Rosaria Capobianchi; Giuseppe Ippolito; Mauro Moroni; Carlo Federico Perno; Antonella d'Arminio Monforte
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.
Journal of biological regulators and homeostatic agents 2002;16(1):37-43.
2002: Priscilla Biswas; Andrea Galli; Brunella Capiluppi; Donatella Ciuffreda; Adriano Lazzarin; Giuseppe Tambussi
Selective enrichment of CD30-expressing cells within the blast region of lymphocytes from patients with primary HIV infection (PHI).
Journal of biological regulators and homeostatic agents 2002;16(1):33-6.
2001: Ferdinand W N M Wit; Robin Wood; Andrzej Horban; Marek Beniowski; Reinhold E Schmidt; Glenda Gray; Adriano Lazzarin; A Lafeuillade; D Paes; Hilde Carlier; L van Weert; C de Vries; Remko van Leeuwen; Joep M A Lange
Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine.
AIDS (London, England) 2001;15(18):2423-9.
2001: Andrew N Phillips; Christian Pradier; Adriano Lazzarin; Bonaventura Clotet; Frank-Detlef Goebel; P Hermans; Francisco Antunes; bruno ledergerber; Ole Kirk; Jens D Lundgren
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients.
AIDS (London, England) 2001;15(18):2385-95.
2001: Flavia B Lillo; Davide Ferrari; Fabrizio Veglia; Massimo Origoni; Maria Antonietta Grasso; Sara Lodini; E Mastrorilli; Gianluca Taccagni; Adriano Lazzarin; Caterina Uberti-Foppa
Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
The Journal of infectious diseases 2001;184(5):547-51.
2001: Paola Cinque; Chiara Pierotti; M G Viganò; Arabella Bestetti; C Fausti; Davide Bertelli; Adriano Lazzarin
The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.
Journal of neurovirology 2001;7(4):358-63.
2001: Giovanni Sitia; D Cella; Maria Stella De Mitri; Roberto Novati; C U Foppa; K Perackis; C Bianchi; Adriano Lazzarin; Giulia Morsica
Evolution of the E2 region of hepatitis C virus in an infant infected by mother-to-infant transmission.
Journal of medical virology 2001;64(4):476-81.
2001: Simona Bossolasco; A Nilsson; Angelo De Milito; Adriano Lazzarin; Annika Linde; Paola Cinque; Francesca Chiodi
Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain.
AIDS (London, England) 2001;15(9):1109-13.
2001: Giuseppe Tambussi; Silvia Ghezzi; Silvia Nozza; Giuliana Vallanti; L Magenta; Monica Guffanti; A Brambilla; Elisa Vicenzi; Paola Carrera; Sara Racca; Laura Soldini; Nicola Gianotti; Michelangelo Murone; Fabrizio Veglia; Guido Poli; Adriano Lazzarin
Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.
The Journal of infectious diseases 2001;183(10):1476-84.
2001: Anna M Brambilla; Antonella Castagna; B Nocita; Hamid Hasson; Enzo Boeri; F Veglia; Adriano Lazzarin
Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections.
Journal of acquired immune deficiency syndromes (1999) 2001;27(1):44-8.
2001: Nicola Gianotti; Giuseppe Tambussi; Enzo Boeri; Adriano Lazzarin
Comparison of protease genotype and phenotype in HIV-1 infected patients exposed to more than one protease inhibitor.
Journal of biological regulators and homeostatic agents 2001;15(2):166-9.
2001: Chiara Bovolenta; L Camorali; Massimiliano Mauri; Silvia Ghezzi; Silvia Nozza; Giuseppe Tambussi; Adriano Lazzarin; Guido Poli
Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals.
Clinical immunology (Orlando, Fla.) 2001;99(1):75-81.
2001: Paola Cinque; Silvia Presi; Arabella Bestetti; Chiara Pierotti; Sara Racca; Enzo Boeri; P Morelli; Paola Carrera; M Ferrari; Adriano Lazzarin
Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid.
AIDS research and human retroviruses 2001;17(5):377-83.
2001: Arabella Bestetti; Chiara Pierotti; MR Terreni; A Zappa; Luca Vago; Adriano Lazzarin; Paola Cinque
Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis.
Journal of clinical microbiology 2001;39(3):1148-51.
2001: Massimo Alfano; Giuliana Vallanti; Priscilla Biswas; Chiara Bovolenta; Elisa Vicenzi; Barbara Mantelli; Tatiana Pushkarsky; R Rappuoli; Adriano Lazzarin; Michael Bukrinsky; Guido Poli
The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(3):1863-70.
2001: Amanda Mocroft; Andrew N Phillips; Veronica Miller; José M Gatell; Jan van Lunzen; J M Parkin; R Weber; B Roge; Adriano Lazzarin; Jens D Lundgren
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study.
AIDS (London, England) 2001;15(2):201-9.
2001: Priscilla Biswas; Barbara Mantelli; Fanny Delfanti; M Cota; Giuliana Vallanti; M Mengozzi; Elisa Vicenzi; Adriano Lazzarin; Guido Poli
Tumor necrosis factor-alpha drives HIV-1 replication in U937 cell clones and upregulates CXCR4.
Cytokine 2001;13(1):55-59.
2001: Adriano Lazzarin; Mario Clerici; Hamid Hasson; L Fumagalli; Pasquale Ferrante; Abby R Saniabadi; M Adachi; Alberto Beretta
Immunovirological improvement in partially HAART responder HIV-infected patients by monocyte adsorption apheresis.
Journal of clinical apheresis 2001;16(1):35-6.
2001: Giulia Morsica; Giovanni Sitia; MT Bernardi; Giuseppe Tambussi; Roberto Novati; Anna de Bona; Nicola Gianotti; Adriano Lazzarin
Acute self-limiting hepatitis C after possible sexual exposure: sequence analysis of the E-2 region of the infected patient and sexual partner.
Scandinavian journal of infectious diseases 2001;33(2):116-20.
2000: R Bures; Alicia Gaitan; T Zhu; C Graziosi; Kevin M McGrath; Jim Tartaglia; P Caudrelier; Raphaelle El Habib; M Klein; Adriano Lazzarin; Donald Stablein; Mark Deers; Lawrence Corey; ML Greenberg; David H Schwartz; David C Montefiori
Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.
AIDS research and human retroviruses 2000;16(18):2019-35.
2000: Marco Floridia; C Tomino; Raffaella Bucciardini; D Ricciardulli; Vincenzo Fragola; Maria F Pirillo; Roberta Amici; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; AC Seeber; Adriana Ammassari; A Cingolani; Adriano Lazzarin; G Scalise; Antonietta Cargnel; Fredy Suter; F Milazzo; G Pastore; Mauro Moroni; R Ciammarughi; R Pini; Giampiero Carosi; C D'Amato; L Contu; Ercole Concia; L Bonazzi; Fernando Aiuti; Gianmarco Vigevani; STEFANO VELLA
A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.
AIDS research and human retroviruses 2000;16(17):1809-20.
2000: Fanny Delfanti; Fabrizio Veglia; Guido Poli; Adriano Lazzarin; Priscilla Biswas
Ex vivo modulation of RANTES and sCD30 by proinflammatory stimuli in HIV-seropositive and -negative individuals.
Clinical immunology (Orlando, Fla.) 2000;97(2):102-8.
2000: Elisa Vicenzi; Silvia Ghezzi; A Brambilla; Haynes W Sheppard; Adriano Lazzarin; Guido Poli; Nelson L Michael
CCR2-64I polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression.
The Journal of infectious diseases 2000;182(5):1579-80.
2000: G Paolo Rizzardi; Giuseppe Tambussi; Pierre-Alexandre Bart; AG Chapuis; Adriano Lazzarin; Giuseppe Pantaleo
Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.
AIDS (London, England) 2000;14(15):2257-63.
2000: Pierre-Alexandre Bart; G Paolo Rizzardi; Giuseppe Tambussi; Jean-Philippe Chave; AG Chapuis; C Graziosi; Jean-Marc Corpataux; N Halkic; Jean-Yves Meuwly; Miguel Munoz; Pascal R A Meylan; W Spreen; H McDade; Sabine Yerly; Luc Perrin; Adriano Lazzarin; Giuseppe Pantaleo
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.
AIDS (London, England) 2000;14(13):1887-97.
2000: Giovanni Rezza; Alessandro Cozzi Lepri; Antonella d'Arminio Monforte; Patrizio Pezzotti; F Castelli; Ferdinando Dianzani; Adriano Lazzarin; Andrea De Luca; Massimo Arlotti; Francesco Leoncini; Paolo E Manconi; Giuliano Rizzardini; L Minoli; Antonio Poggio; Giuseppe Ippolito; Andrew N Phillips; Mauro Moroni
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group.
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):56-62.
2000: Elisa Vicenzi; Massimo Alfano; Silvia Ghezzi; A Gatti; Fabrizio Veglia; Adriano Lazzarin; Silvano Sozzani; Alberto Mantovani; Guido Poli
Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
Journal of leukocyte biology 2000;68(3):405-12.
2000: Brunella Capiluppi; Donatella Ciuffreda; M Sciandra; M Marroni; Giuseppe Tambussi; Adriano Lazzarin
Metabolic disorders in a cohort of patients treated with highly aggressive antiretroviral therapies during primary HIV-1 infection.
AIDS (London, England) 2000;14(12):1861-2.
2000: Giulia Morsica; Anna de Bona; C U Foppa; Giovanni Sitia; Renato Finazzi; Adriano Lazzarin
Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment.
AIDS (London, England) 2000;14(11):1656-8.
2000: A Brambilla; C Villa; G Paolo Rizzardi; Fabrizio Veglia; Silvia Ghezzi; Adriano Lazzarin; Marco Cusini; S Muratori; Elena Santagostino; Alessandro Gringeri; Leslie G Louie; Haynes W Sheppard; Guido Poli; Nelson L Michael; Giuseppe Pantaleo; Elisa Vicenzi
Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 2000;182(1):311-5.
2000: Giuseppe Tambussi; Andrea Gori; Brunella Capiluppi; Claudia Balotta; Laura Papagno; B Morandini; M Di Pietro; Donatella Ciuffreda; A Saracco; Adriano Lazzarin
Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(6):962-5.
2000: Sylvain Fleury; G Paolo Rizzardi; AG Chapuis; Giuseppe Tambussi; C Knabenhans; Eleonora Simeoni; Jean-Yves Meuwly; Jean-Marc Corpataux; Adriano Lazzarin; Frank Miedema; Giuseppe Pantaleo
Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(10):5393-8.
2000: Lucia Lopalco; Claudia Barassi; Claudia Pastori; Renato Longhi; Samuele E Burastero; Giuseppe Tambussi; Francesco Mazzotta; Adriano Lazzarin; Mario Clerici; Antonio G Siccardi
CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(6):3426-33.
2000: G Paolo Rizzardi; Rob J De Boer; S Hoover; Giuseppe Tambussi; AG Chapuis; N Halkic; Pierre-Alexandre Bart; V Miller; S Staszewski; Daan W Notermans; Luc Perrin; CH Fox; J M Lange; Adriano Lazzarin; Giuseppe Pantaleo
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.
The Journal of clinical investigation 2000;105(6):777-82.
2000: H Soudeyns; G Campi; G Paolo Rizzardi; C Lenge; JF Demarest; Giuseppe Tambussi; Adriano Lazzarin; Daniel Kaufmann; Giulia Casorati; Lawrence Corey; Giuseppe Pantaleo
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality.
Blood 2000;95(5):1743-51.
2000: Lucia Lopalco; Claudia Pastori; Antonio Cosma; Samuele E Burastero; Brunella Capiluppi; Enzo Boeri; Alberto Beretta; Adriano Lazzarin; Antonio G Siccardi
Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.
AIDS research and human retroviruses 2000;16(2):109-15.
2000: L Fumagalli; Massimo Zucchetti; I Parisi; M G Viganò; B Zecca; A Careddu; Maurizio D'Incalci; Adriano Lazzarin
The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma.
Cancer chemotherapy and pharmacology 2000;45(6):495-501.
2000: G Paolo Rizzardi; M Vaccarezza; Brunella Capiluppi; Giuseppe Tambussi; Adriano Lazzarin; Giuseppe Pantaleo
Cyclosporin A in combination with HAART in primary HIV-1 infection.
Journal of biological regulators and homeostatic agents 2000;14(1):79-81.
2000: Claudia Barassi; C De Santis; Claudia Pastori; P Marraccini; Donatella Ciuffreda; Brunella Capiluppi; C Bressi; Antonio G Siccardi; Adriano Lazzarin; Giuseppe Tambussi; Lucia Lopalco
Early production of HIV-1 neutralising antibodies in patients following highly active antiretroviral treatment (HAART) during primary HIV infection.
Journal of biological regulators and homeostatic agents 2000;14(1):68-74.
2000: Donatella Ciuffreda; Brunella Capiluppi; E Mastrorilli; G Balconi; Giuseppe Tambussi; Adriano Lazzarin; Flavia B Lillo
Primary HIV infection: molecular approaches in diagnosis and monitoring.
Journal of biological regulators and homeostatic agents 2000;14(1):63-7.
2000: Brunella Capiluppi; Donatella Ciuffreda; G P Quinzan; M Sciandra; M Marroni; B Morandini; P Costigliola; L Guerra; M Di Pietro; G F Fibbia; R Visonà; M Cusini; C Bressi; Giuseppe Tambussi; Adriano Lazzarin
Four drug-HAART in primary HIV-1 infection: clinical benefits and virologic parameters.
Journal of biological regulators and homeostatic agents 2000;14(1):58-62.
2000: Giuliana Vallanti; Chiara Bovolenta; A Brambilla; Giuseppe Tambussi; Adriano Lazzarin; Elisa Vicenzi; Guido Poli
Immunologic reconstitution by interleukin-2: facts and open questions.
Journal of biological regulators and homeostatic agents 2000;14(1):41-4.
2000: Alberto Beretta; Mario Clerici; Hamid Hasson; L Fumagalli; Daria Trabattoni; Flavia B Lillo; Pasquale Ferrante; Abby R Saniabadi; M Adachi; Adriano Lazzarin
Ex-vivo purging of circulating monocytes results in immunovirologic improvement in partially HAART responder HIV-infected patients.
Journal of biological regulators and homeostatic agents 2000;14(1):27-31.
2000: Alessandra Cenci; Ada Bertoli; Giuseppe Tambussi; S Menzo; Massimo Clementi; Adriano Lazzarin; Brunella Capiluppi; Donatella Ciuffreda; Federica Forbici; Stefano Aquaro; F Marcuccilli; Raffaele Caliò; Carlo Federico Perno
Viral dynamics and mutations in the pol gene during primary HIV-1 infection.
Journal of biological regulators and homeostatic agents 2000;14(1):7-10.
2000: B Giudici; B Vaz; Simona Bossolasco; Salvatore Casari; Anna Maria Brambilla; Wolfgang Lüke; Adriano Lazzarin; T Weber; Paola Cinque
Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(1):95-9.
2000: L La Maestra; Anna Zaninoni; J Blake Marriott; Adriano Lazzarin; Angus G Dalgleish; Wilma Barcellini
The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.
Clinical and experimental immunology 2000;119(1):123-9.
1999: Chiara Bovolenta; L Camorali; AL Lorini; Silvia Ghezzi; Elisa Vicenzi; Adriano Lazzarin; Guido Poli
Constitutive activation of STATs upon in vivo human immunodeficiency virus infection.
Blood 1999;94(12):4202-9.
1999: Chiara Bovolenta; L Camorali; AL Lorini; Giuliana Vallanti; Silvia Ghezzi; Giuseppe Tambussi; Adriano Lazzarin; Guido Poli
In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors ying-yang-1 and leader binding protein-1/late simian virus 40 factor.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(12):6892-7.
1999: Amanda Mocroft; Sara Madge; Anne M Johnson; Adriano Lazzarin; Nathan Clumeck; Frank-Detlef Goebel; Jean-Paul Viard; José M Gatell; Anders Blaxhult; Jens D Lundgren
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival.
Journal of acquired immune deficiency syndromes (1999) 1999;22(4):369-78.
1999: Simona Bossolasco; Roberta Marenzi; H Dahl; Luca Vago; MR Terreni; Francesco Broccolo; Adriano Lazzarin; Annika Linde; Paola Cinque
Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance.
Journal of neurology, neurosurgery, and psychiatry 1999;67(6):789-92.
1999: Claudio Fortis; Priscilla Biswas; Laura Soldini; Fabrizio Veglia; Anna M Careddu; Fanny Delfanti; Barbara Mantelli; Michelangelo Murone; Adriano Lazzarin; Guido Poli
Dual role of TNF-alpha in NK/LAK cell-mediated lysis of chronically HIV-infected U1 cells. Concomitant enhancement of HIV expression and sensitization of cell-mediated lysis.
European journal of immunology 1999;29(11):3654-62.
1999: Paolo Scarpellini; S Braglia; Paola Carrera; M Cedri; Paola Cichero; A Colombo; R Crucianelli; Andrea Gori; M Ferrari; Adriano Lazzarin
Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis.
Antimicrobial agents and chemotherapy 1999;43(10):2550-4.
1999: M Henry; Aumaid Uthman; Alexandra Geusau; A Rieger; Lucinda Furci; Adriano Lazzarin; Paolo Lusso; Erwin Tschachler
Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma.
The Journal of investigative dermatology 1999;113(4):613-6.
1999: Lucia Lopalco; ZI Magnani; C Confetti; M Brianza; A Saracco; G Ferraris; Flavia B Lillo; Chiara Vegni; Adriano Lazzarin; Antonio G Siccardi; Samuele E Burastero
Anti-CD4 antibodies in exposed seronegative adults and in newborns of HIV type 1-seropositive mothers: a follow-up study.
AIDS research and human retroviruses 1999;15(12):1079-85.
1999: Anna Maria Brambilla; Antonella Castagna; Roberto Novati; Paola Cinque; MR Terreni; Maria Cristina Moioli; Adriano Lazzarin
Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy.
Journal of neurology 1999;246(8):723-5.
1999: Giulia Morsica; Giuseppe Tambussi; Giovanni Sitia; Roberto Novati; Adriano Lazzarin; Lucia Lopalco; S Mukenge
Replication of hepatitis C virus in B lymphocytes (CD19+)
Blood 1999;94(3):1138-9.
1999: Nicola Gianotti; Francesca Moretti; Giuseppe Tambussi; Brunella Capiluppi; M Ferrari; Adriano Lazzarin
The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogs.
Journal of biological regulators and homeostatic agents 1999;13(3):158-62.
1999: Flavia B Lillo; Donatella Ciuffreda; Fabrizio Veglia; Brunella Capiluppi; E Mastrorilli; B Vergani; Giuseppe Tambussi; Adriano Lazzarin
Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection.
AIDS (London, England) 1999;13(7):791-6.
1999: Caterina Uberti-Foppa; Anna de Bona; Giulia Morsica; Monica Guffanti; Nicola Gianotti; Enzo Boeri; Adriano Lazzarin
Recombinant interleukin-2 for treatment of HIV reduces hepatitis C viral load in coinfected patients.
AIDS (London, England) 1999;13(1):140-1.
1999: Nicola Gianotti; Francesca Moretti; Giuseppe Tambussi; Sara Racca; Silvia Presi; R Crucianelli; Paola Carrera; M Ferrari; Adriano Lazzarin
Study on mutations and antiretroviral therapy (SMART): preliminary results.
Antiviral therapy 1999;4 Suppl 3():65-9.
1998: G Paolo Rizzardi; J Blake Marriott; S Cookson; Adriano Lazzarin; Angus G Dalgleish; Wilma Barcellini
Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2-type response.
Clinical and experimental immunology 1998;114(1):61-5.
1998: Caterina Uberti-Foppa; Massimo Origoni; M Maillard; Davide Ferrari; Donatella Ciuffreda; E Mastrorilli; Adriano Lazzarin; Flavia B Lillo
Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
Journal of medical virology 1998;56(2):133-7.
1998: Paola Cinque; Luca Vago; Roberta Marenzi; B Giudici; T Weber; R Corradini; D Ceresa; Adriano Lazzarin; Annika Linde
Herpes simplex virus infections of the central nervous system in human immunodeficiency virus-infected patients: clinical management by polymerase chain reaction assay of cerebrospinal fluid.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(2):303-9.
1998: Paola Cinque; Luca Vago; M Mengozzi; V Torri; D Ceresa; Elisa Vicenzi; P Transidico; A Vagani; Silvano Sozzani; Alberto Mantovani; Adriano Lazzarin; Guido Poli
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication.
AIDS (London, England) 1998;12(11):1327-32.
1998: Caterina Uberti-Foppa; Flavia B Lillo; Maria Rosa Terreni; A Puglisi; Monica Guffanti; Nicola Gianotti; Adriano Lazzarin
Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease.
Chest 1998;113(4):919-23.
1998: Paola Cinque; Luca Vago; D Ceresa; F Mainini; MR Terreni; A Vagani; W Torri; Simona Bossolasco; Adriano Lazzarin
Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis.
AIDS (London, England) 1998;12(4):389-94.
1998: G Paolo Rizzardi; R A Morawetz; Elisa Vicenzi; Silvia Ghezzi; Guido Poli; Adriano Lazzarin; Giuseppe Pantaleo
CCR2 polymorphism and HIV disease. Swiss HIV Cohort.
Nature medicine 1998;4(3):252-3.
1998: Giuseppe Tambussi; Enzo Boeri; Paola Carrera; Nicola Gianotti; Adriano Lazzarin
Prevalence of mutation associated to resistance with nucleoside analogues in a cohort of naïve HIV-1 positive subjects during the period 1984-1997.
Journal of biological regulators and homeostatic agents 1998;12(1-2 Suppl):32-4.
1998: Priscilla Biswas; Fanny Delfanti; Sergio Bernasconi; M Mengozzi; M Cota; Nadia Polentarutti; Alberto Mantovani; Adriano Lazzarin; Silvano Sozzani; Guido Poli
Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line.
Blood 1998;91(1):258-65.
1997: R A Morawetz; G Paolo Rizzardi; D Glauser; Olivier T Rutschmann; Bernard Hirschel; Luc Perrin; Milos Opravil; Markus Flepp; Jan von Overbeck; Michel-Pierre Glauser; Silvia Ghezzi; Elisa Vicenzi; Guido Poli; Adriano Lazzarin; Giuseppe Pantaleo
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.
European journal of immunology 1997;27(12):3223-7.
1997: Lucinda Furci; Alberto Beretta; Antonio G Siccardi; Adriano Lazzarin; C Confetti; ZI Magnani; Paolo Scarpellini; Lucia Lopalco; Samuele E Burastero
Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects.
AIDS research and human retroviruses 1997;13(17):1461-9.
1997: Giulia Morsica; MT Bernardi; Roberto Novati; Caterina Uberti-Foppa; Antonella Castagna; Adriano Lazzarin
Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients.
Journal of medical virology 1997;53(3):252-4.
1997: D Gambini; A Brambilla; C Galli; Antonella Castagna; F Veglia; Adriano Lazzarin
Increased hyperglycaemia during cotreatment with pentamidine and corticosteroids in AIDS patients.
AIDS (London, England) 1997;11(13):1652-3.
1997: Paolo Scarpellini; S Braglia; Anna M Brambilla; M Dalessandro; Paola Cichero; Andrea Gori; Adriano Lazzarin
Detection of rifampin resistance by single-strand conformation polymorphism analysis of cerebrospinal fluid of patients with tuberculosis of the central nervous system.
Journal of clinical microbiology 1997;35(11):2802-6.
1997: Dario Roccatello; Giulia Morsica; Giuseppe Picciotto; Giulio Cesano; Roberto Ropolo; MT Bernardi; Giovanni Cacace; Guido Cavalli; Luigi M Sena; Adriano Lazzarin; Giuseppe Piccoli; Abdalla Rifai
Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection.
Clinical and experimental immunology 1997;110(1):9-14.
1997: Nicola Gianotti; Paola Cinque; Antonella Castagna; Roberto Novati; M Moro; Adriano Lazzarin
Diagnosis of toxoplasmic encephalitis in HIV-infected patients.
AIDS (London, England) 1997;11(12):1529-30.
1997: Antonella Castagna; Paola Cinque; A d'Amico; Cristina Messa; Ferruccio Fazio; Adriano Lazzarin
Evaluation of contrast-enhancing brain lesions in AIDS patients by means of Epstein-Barr virus detection in cerebrospinal fluid and 201thallium single photon emission tomography.
AIDS (London, England) 1997;11(12):1522-3.
1997: Paola Cinque; Simona Bossolasco; Luca Vago; C Fornara; S Lipari; Sara Racca; Adriano Lazzarin; Annika Linde
Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(3):634-9.
1997: Lucinda Furci; Gabriella Scarlatti; Samuele E Burastero; Giuseppe Tambussi; C Colognesi; C Quillent; Renato Longhi; P Loverro; B Borgonovo; D Gaffi; E Carrow; Mauro S Malnati; Paolo Lusso; Antonio G Siccardi; Adriano Lazzarin; Alberto Beretta
Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele.
The Journal of experimental medicine 1997;186(3):455-60.
1997: A D'Amico; Cristina Messa; Antonella Castagna; F Zito; Laura Galli; G Pepe; Adriano Lazzarin; giovanni lucignani; Ferruccio Fazio
Diagnostic accuracy and predictive value of 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients.
Nuclear medicine communications 1997;18(8):741-50.
1997: G Paolo Rizzardi; G Tambussi; Adriano Lazzarin
Acute pancreatitis during primary HIV-1 infection.
The New England journal of medicine 1997;336(25):1836-7.
1997: Anna Danise; Paola Cinque; S Vergani; M Candino; Sara Racca; Anna de Bona; Roberto Novati; Antonella Castagna; Adriano Lazzarin
Use of polymerase chain reaction assays of aqueous humor in the differential diagnosis of retinitis in patients infected with human immunodeficiency virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(6):1100-6.
1997: Antonella d'Arminio Monforte; Massimo Musicco; Massimo Galli; C Paga; A La Regina; Adriano Lazzarin; Gioacchino Angarano; F Milazzo; F Gritti; Massimo Arlotti; Francesco Mazzotta; G Visco; Fernando Aiuti; Mauro Moroni
Italian multicentre study of didanosine compassionate use in advanced HIV infection. Italian BMS-906 Study Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(2):135-42.
1997: Giuseppe Pantaleo; JF Demarest; T Schacker; M Vaccarezza; OJ Cohen; Marybeth Daucher; C Graziosi; S S Schnittman; Thomas C Quinn; G M Shaw; Luc Perrin; Giuseppe Tambussi; Adriano Lazzarin; Rafick-Pierre Sekaly; H Soudeyns; Lawrence Corey; Anthony Fauci
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(1):254-8.
1997: Silvia Ghezzi; Elisa Vicenzi; Laura Soldini; Giuseppe Tambussi; Michelangelo Murone; Adriano Lazzarin; Guido Poli
Experiences in immune reconstitution. The rationale for interleukin-2 administration to HIV-infected individuals.
Journal of biological regulators and homeostatic agents 1997;11(1-2):74-8.
1997: Brunella Capiluppi; E Castelli; E Clerici; A Pan; L Tomasoni; Adriano Lazzarin
Primary HIV infection: therapeutic strategies.
Journal of biological regulators and homeostatic agents 1997;11(1-2):56-9.
1997: Giuseppe Tambussi; Flavia B Lillo; Brunella Capiluppi; E Clerici; Andrea Gori; M D Pietro; G Gavazzeni; B Morandini; Adriano Lazzarin
Primary HIV infection: clinical aspects and monitoring.
Journal of biological regulators and homeostatic agents 1997;11(1-2):53-5.
1997: G Paolo Rizzardi; Giuseppe Tambussi; Wilma Barcellini; Brunella Capiluppi; E Clerici; L L Maestra; Flavia B Lillo; Giuseppe Pantaleo; Adriano Lazzarin
Soluble CD30, tumour necrosis factor (TNF)-alpha, and TNF receptors in primary HIV-1 infection: relationship with HIV-1, RNA, clinical outcome and early antiviral therapy.
Journal of biological regulators and homeostatic agents 1997;11(1-2):43-9.
1997: Mauro S Malnati; Giuseppe Tambussi; E Clerici; S Polo; M Algeri; V Nardese; Lucinda Furci; Adriano Lazzarin; Paolo Lusso
Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection.
Journal of biological regulators and homeostatic agents 1997;11(1-2):40-2.
1997: Lucia Lopalco; Claudia Pastori; Claudia Barassi; Lucinda Furci; Samuele E Burastero; Flavia B Lillo; Enzo Boeri; Laura Soldini; Giuseppe Tambussi; Adriano Lazzarin; Alberto Beretta; Antonio G Siccardi
Heterogeneity in exposed uninfected individuals.
Journal of biological regulators and homeostatic agents 1997;11(1-2):27-31.
1997: P Cinque; Paolo Scarpellini; Luca Vago; A Linde; Adriano Lazzarin
Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction.
AIDS (London, England) 1997;11(1):1-17.
1997: Antonella d'Arminio Monforte; Paola Cinque; Luca Vago; A Rocca; Antonella Castagna; Cristina Gervasoni; MR Terreni; Roberto Novati; A Gori; Adriano Lazzarin; Mauro Moroni
A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients.
Journal of neurology 1997;244(1):35-9.
1997: Elisa Vicenzi; Patrizia Bagnarelli; Elena Santagostino; Silvia Ghezzi; Massimo Alfano; M S Sinnone; Giovanna Fabio; L Turchetto; G Moretti; Adriano Lazzarin; A Mantovani; P M Mannucci; M Clementi; Alessandro Gringeri; Guido Poli
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection.
Blood 1997;89(1):191-200.
1996: G Paolo Rizzardi; Wilma Barcellini; Giuseppe Tambussi; Flavia B Lillo; Mauro S Malnati; L Perrin; Adriano Lazzarin
Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.
AIDS (London, England) 1996;10(13):F45-50.
1996: S Bernasconi; Paola Cinque; G Peri; Silvano Sozzani; A Crociati; W Torri; Elisa Vicenzi; Luca Vago; Adriano Lazzarin; G Poli; A Mantovani
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
The Journal of infectious diseases 1996;174(5):1098-101.
1996: STEFANO VELLA; Adriano Lazzarin; G Carosi; Alessandro Sinicco; O Armignacco; G Angarano; Massimo Andreoni; G Tambussi; A Chiodera; Marco Floridia; S Scaccabarozzi; K Facey; I Duncan; P Boudes; K Bragman
A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
Antiviral therapy 1996;1(3):129-40.
1996: Paola Cinque; Luca Vago; Helena Dahl; Maria Brytting; M R Terreni; Carla Fornara; Sara Racca; Antonella Castagna; A D Monforte; B Wahren; Adriano Lazzarin; A Linde
Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients.
AIDS (London, England) 1996;10(9):951-8.
1996: Alberto Beretta; Lucinda Furci; Samuele E Burastero; Antonio Cosma; M E Dinelli; Lucia Lopalco; C DeSantis; Giuseppe Tambussi; E Carrow; S Sabbatani; Mario Clerici; Adriano Lazzarin; Antonio G Siccardi
HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection.
Immunology letters 1996;51(1-2):39-43.
1996: Bruno Grassi; M Locatelli; Adriano Lazzarin; Silvio Scarone
Temporal lobe electroencephalogram power modifications during olfactory stimulation in HIV-infected patients.
AIDS research and human retroviruses 1996;12(6):547-51.
1996: Wilma Barcellini; G Paolo Rizzardi; G Poli; Giuseppe Tambussi; C Velati; P L Meroni; Angus G Dalgleish; Adriano Lazzarin
Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection.
AIDS research and human retroviruses 1996;12(4):325-31.
1996: Samuele E Burastero; D Gaffi; Lucia Lopalco; Giuseppe Tambussi; B Borgonovo; C De Santis; C Abecasis; P Robbioni; Anna Gasparri; Adriano Lazzarin; F Celada; Antonio G Siccardi; Alberto Beretta
Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals.
AIDS research and human retroviruses 1996;12(4):273-80.
1996: G Paolo Rizzardi; Adriano Lazzarin; M Musicco; D Frigerio; M Maillard; M Lucchini; Mauro Moroni
Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
The Journal of infection 1996;32(2):123-31.
1996: Roberta Marenzi; Paola Cinque; D Ceresa; Sara Racca; Flavia B Lillo; Adriano Lazzarin
Serum polymerase chain reaction for cytomegalovirus DNA for monitoring ganciclovir treatment in AIDS patients.
Scandinavian journal of infectious diseases 1996;28(4):347-51.
1995: G Paolo Rizzardi; Adriano Lazzarin; M Musicco; D Frigerio; M Maillard; M Lucchini; Mauro Moroni
Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. An Italian multicentric randomised controlled trial. The Italian PCP Study Group.
The Journal of infection 1995;31(2):99-105.
1995: Giulia Morsica; Roberto Novati; Adriano Lazzarin
Detection of hepatitis C virus RNA by methods using phenol-chloroform or silica particles.
Journal of clinical microbiology 1995;33(9):2522-3.
1995: Paolo Scarpellini; Sara Racca; Paola Cinque; F Delfanti; Nicola Gianotti; M R Terreni; Luca Vago; Adriano Lazzarin
Nested polymerase chain reaction for diagnosis and monitoring treatment response in AIDS patients with tuberculous meningitis.
AIDS (London, England) 1995;9(8):895-900.
1995: Wilma Barcellini; G Paolo Rizzardi; C Velati; Maria Orietta Borghi; C Fain; Adriano Lazzarin; P L Meroni
In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users.
AIDS (London, England) 1995;9(7):691-4.
1995: Paola Cinque; Fausto Baldanti; Luca Vago; M R Terreni; Flavia B Lillo; Milena Furione; Antonella Castagna; A D Monforte; Adriano Lazzarin; A Linde
Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid.
The Journal of infectious diseases 1995;171(6):1603-6.
1995: Maria Dorrucci; Giovanni Rezza; David Vlahov; Patrizio Pezzotti; Alessandro Sinicco; A Nicolosi; Adriano Lazzarin; Noya Galai; S Gafà; R Pristerà
Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study.
AIDS (London, England) 1995;9(6):597-604.
1995: Giuseppe Tambussi; L Repetto; V Torri; A Saracco; L Moresco; A Antinori; R Zerboni; Adriano Lazzarin
Epidemic HIV-related Kaposi's sarcoma: a retrospective analysis and validation of TIS staging. GICAT. Gruppo Italiano Collaborativo AIDS e Tumori.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(4):383-7.
1995: M Froldi; M Parma; Roberta Marenzi; A Piona; Maurizio Lorini; E Nobile Orazio; Antonella Castagna; Adriano Lazzarin
Low levels of LTB4 in cerebrospinal fluid of AIDS patients with cryptococcal meningitis.
Journal of clinical & laboratory immunology 1995;47(1):41-7.
1995: Paola Cinque; Luca Vago; M R Terreni; Maria Brytting; Roberta Marenzi; Antonella Castagna; Adriano Lazzarin; A Linde
Diagnosis of cytomegalovirus infection of the nervous system in AIDS by polymerase chain reaction analysis of cerebrospinal fluid.
Scandinavian journal of infectious diseases. Supplementum 1995;99():92-4.
1995: Guido Poli; Elisa Vicenzi; Silvia Ghezzi; Adriano Lazzarin
Cytokines in the acquired immunodeficiency syndrome and other infectious diseases.
International journal of clinical & laboratory research 1995;25(3):128-34.
1995: M L Leite; A Nicolosi; A R Osella; S Molinari; E Cozzolino; C Velati; Adriano Lazzarin
Modeling incidence rate ratio and rate difference: additivity or multiplicativity of human immunodeficiency virus parenteral and sexual transmission among intravenous drug users. Northern Italy Seronegative Drug Addicts Study.
American journal of epidemiology 1995;141(1):16-24.
1994: Roberto Novati; Antonella Castagna; Giulia Morsica; Luca Vago; Giuseppe Tambussi; Silvia Ghezzi; Cristina Gervasoni; C Bisson; Antonella d'Arminio Monforte; Adriano Lazzarin
Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions.
AIDS (London, England) 1994;8(12):1691-4.
1994: A Nicolosi; M L Corrêa Leite; Massimo Musicco; C Arici; G Gavazzeni; Adriano Lazzarin
The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission.
Epidemiology (Cambridge, Mass.) 1994;5(6):570-5.
1994: Massimo Musicco; Adriano Lazzarin; A Nicolosi; M Gasparini; P Costigliola; C Arici; A Saracco
Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.
Archives of internal medicine 1994;154(17):1971-6.
1994: A Nicolosi; M Autelitano; M L Corrêa Leite; A R Osella; Adriano Lazzarin
[The sexual transmission of the acquired immunodeficiency virus: the reasons for greater male-to-female than female-to-male transmission efficiency].
Annali di igiene : medicina preventiva e di comunità 1994;6(4-6):641-8.
1994: Wilma Barcellini; G Paolo Rizzardi; Maria Orietta Borghi; C Fain; Adriano Lazzarin; P L Meroni
TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients.
AIDS (London, England) 1994;8(6):757-62.
1994: Giuseppe Tambussi; V Albarello; Andrea Gori; C Bisson; Adriano Lazzarin
Transitory expansion of a CD3+TcR gamma/delta+CD16+ lymphocytic population in two patients with advanced human immunodeficiency virus infection and high levels of natural killer activity.
AIDS research and human retroviruses 1994;10(6):711-5.
1994: Giovanni Rezza; A Nicolosi; Mauro Zaccarelli; Luciano Sagliocca; M Nespoli; P Gattari; L Spizzichino; giuseppe ippolito; Adriano Lazzarin
Understanding the dynamics of the HIV epidemic among Italian intravenous drug users: a cross-sectional versus a longitudinal approach.
Journal of acquired immune deficiency syndromes 1994;7(5):500-3.
1994: A Nicolosi; Massimo Musicco; A Saracco; Adriano Lazzarin
Risk factors for woman-to-man sexual transmission of the human immunodeficiency virus. Italian Study Group on HIV Heterosexual Transmission.
Journal of acquired immune deficiency syndromes 1994;7(3):296-300.
1994: Franco Capsoni; Francesca Minonzio; Anna Maria Ongari; Paola Bonara; G Pinto; V Carbonelli; Adriano Lazzarin; C Zanussi
Fc receptors expression and function in mononuclear phagocytes from AIDS patients: modulation by IFN-gamma.
Scandinavian journal of immunology 1994;39(1):45-50.
1994: Wilma Barcellini; Paola Sacerdote; Maria Orietta Borghi; G Paolo Rizzardi; C Fain; Carlo De Giuli Morghen; Barbara Manfredi; Adriano Lazzarin; P L Meroni; Alberto E Panerai
Beta-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects.
Peptides 1994;15(5):769-75.
1993: Maria Orietta Borghi; C De Santis; Wilma Barcellini; Lucia Lopalco; C Fain; Adriano Lazzarin; Antonio G Siccardi; P L Meroni; C Zanussi; Alberto Beretta
Autoantibodies against beta 2-microglobulin-free HLA antigens in AIDS patients.
Journal of acquired immune deficiency syndromes 1993;6(10):1114-9.
1993: Paola Cinque; Maria Brytting; Luca Vago; Antonella Castagna; Carlo Parravicini; N Zanchetta; Antonella d'Arminio Monforte; Britta Wahren; Adriano Lazzarin; A Linde
Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.
Lancet 1993;342(8868):398-401.
1993: G Landonio; Paola Cinque; A Nosari; S Gafa; F Rizzo; Massimo Coen; U Tirelli; L Caggese; U di Luzio Paparatti; Adriano Lazzarin
Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia.
AIDS (London, England) 1993;7(2):209-12.
1993: Paola Cinque; G Landonio; Adriano Lazzarin; A M Nosari; A Ruggieri; Massimo Coen; P Meraviglia; A Gringeri; L Gallo; Tiziana Quirino
Long-term treatment with zidovudine in patients with human immunodeficiency virus (HIV)-associated thrombocytopenia: modes of response and correlation with markers of HIV replication.
European journal of haematology 1993;50(1):17-21.
1992: Antonella d'Arminio Monforte; F Mainini; Teresa Bini; Paola Cinque; T Formenti; Adriano Lazzarin; Mauro Moroni; M Villa; A Tinazzi
Survival differences for 547 AIDS cases in Milan.
Journal of acquired immune deficiency syndromes 1992;5(12):1276-7.
1992: Paola Cinque; Luca Vago; Maria Brytting; Antonella Castagna; A Accordini; V A Sundqvist; N Zanchetta; A D Monforte; B Wahren; Adriano Lazzarin
Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid.
The Journal of infectious diseases 1992;166(6):1408-11.
1992: Franco Capsoni; Francesca Minonzio; G Colombo; Anna Maria Ongari; Paola Bonara; G Paolo Rizzardi; Adriano Lazzarin; C Zanussi
Membrane expression and function of complement receptors CR1 and CR3 on neutrophils from HIV-infected subjects: modulation by rTNF-alpha and rGM-CSF.
Scandinavian journal of immunology 1992;36(4):541-6.
1992: Antonella d'Arminio Monforte; Luca Vago; Adriano Lazzarin; Renzo Boldorini; Teresa Bini; Stefano Guzzetti; Spinello Antinori; Mauro Moroni; Giulio Costanzi
AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses.
AIDS (London, England) 1992;6(10):1159-64.
1992: Nicola Gianotti; R Finazzi; Caterina Uberti-Foppa; A Danise; T Migone; Adriano Lazzarin
The thymic hormones in the treatment of immune deficiency related to HIV infection.
Pharmacological research : the official journal of the Italian Pharmacological Society 1992;26 Suppl 2():62-3.
1992: M Froldi; Antonella Castagna; M Parma; A Piona; Alberto Tedeschi; Antonio Miadonna; Maurizio Lorini; E N Orazio; Adriano Lazzarin
Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement.
Journal of neuroimmunology 1992;38(1-2):155-61.
1992: Roberto Novati; Valérie Thiers; A D Monforte; P Maisonneuve; Nicola Principi; M Conti; Adriano Lazzarin; C Brechot
Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction.
The Journal of infectious diseases 1992;165(4):720-3.
1992: Franco Capsoni; Francesca Minonzio; Anna Maria Ongari; G Paolo Rizzardi; Adriano Lazzarin; C Zanussi
Monocyte-derived macrophage function in HIV-infected subjects: in vitro modulation by rIFN-gamma and rGM-CSF.
Clinical immunology and immunopathology 1992;62(2):176-82.
1992: A Nicolosi; M L Leite; Massimo Musicco; S Molinari; Adriano Lazzarin
Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study.
American journal of epidemiology 1992;135(3):225-33.
1992: Adriano Lazzarin; Antonella Castagna; Guido Cavalli; M C Amprimo; M Vaj; Carlo Parravicini; Giulio Costanzi; Paolo Ronchi; C U Foppa; Mauro Moroni; R Turconi
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement.
Journal of clinical & laboratory immunology 1992;38(4):175-86.
1992: Giovanna Fabio; Raffaella Scorza; Adriano Lazzarin; M Marchini; M Zarantonello; A D'Arminio; Paola Marchisio; Alessandro Plebani; Roberto Luzzati; P Costigliola
HLA-associated susceptibility to HIV-1 infection.
Clinical and experimental immunology 1992;87(1):20-3.
1992: Patrizio Pezzotti; Giovanni Rezza; Adriano Lazzarin; G Angarano; Alessandro Sinicco; Fernando Aiuti; R Zerboni; Bernardino Salassa; S Gafà; R Pristerà
Influence of gender, age, and transmission category on the progression from HIV seroconversion to AIDS.
Journal of acquired immune deficiency syndromes 1992;5(7):745-7.
1992: A Nicolosi; M L Leite; S Molinari; Massimo Musicco; A Saracco; Adriano Lazzarin
Incidence and prevalence trends of HIV infection in intravenous drug users attending treatment centers in Milan and northern Italy, 1986-1990.
Journal of acquired immune deficiency syndromes 1992;5(4):365-73.
1992: Giovanni Rezza; Fausto Titti; Patrizio Pezzotti; Leonardo Sernicola; S Lo Caputo; G Angarano; Adriano Lazzarin; Alessandro Sinicco; G B Rossi; Paola Verani
Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
Journal of biological regulators and homeostatic agents 1992;6(1):15-20.
1991: S Procaccia; R Blasio; P Villa; Adriano Lazzarin; C Bonacina; Roberto Novati; Teresa Bini; M Memoli; N Imondi; C Zanussi
Rheumatoid factors and circulating immune complexes in HIV-infected individuals.
AIDS (London, England) 1991;5(12):1441-6.
1991: Adriano Lazzarin; A Saracco; Massimo Musicco; A Nicolosi
Man-to-woman sexual transmission of the human immunodeficiency virus. Risk factors related to sexual behavior, man's infectiousness, and woman's susceptibility. Italian Study Group on HIV Heterosexual Transmission.
Archives of internal medicine 1991;151(12):2411-6.
1991: Carlo Parravicini; Giorgio Baroldi; G Gaiera; Adriano Lazzarin
Phenotype of intramyocardial leukocytic infiltrates in acquired immunodeficiency syndrome (AIDS): a postmortem immunohistochemical study in 34 consecutive cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1991;4(5):559-65.
1991: L M Grimaldi; Antonella Castagna; D Maimone; Gianvito Martino; A Dolci; R Pristera; Adriano Lazzarin; R P Roos
Kappa light chain predominance in serum and cerebrospinal fluid from human immunodeficiency virus type 1 (HIV-1)-infected patients.
Journal of neuroimmunology 1991;32(3):259-68.
1991: N Eisera; Giovanna Fabio; M Marchini; M Zarantonello; Adriano Lazzarin; R Scorza
HLA-B35 and thrombocytopenia in drug users with AIDS.
The Journal of infectious diseases 1991;163(4):926-7.
1991: C U Foppa; Teresa Bini; G Gregis; Adriano Lazzarin; R Esposito; Mauro Moroni
A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(3):187-9.
1991: C Negri; A Saracco; Adriano Lazzarin
Use of central venous catheterization for AIDS patients.
Journal of acquired immune deficiency syndromes 1991;4(5):543.
1991: A Nicolosi; S Molinari; Massimo Musicco; A Saracco; N Ziliani; Adriano Lazzarin
Positive modification of injecting behavior among intravenous heroin users from Milan and northern Italy 1987-1989. NISDA Study.
British journal of addiction 1991;86(1):91-102.
1991: C Negri; A Saracco; Giuseppe Tambussi; A Ruggieri; Adriano Lazzarin
[Respiratory complications in 44 patients with acquired immunodeficiency syndrome].
Bollettino dell'Istituto sieroterapico milanese 1991;70(1-2):487-93.
1990: A Nicolosi; Massimo Musicco; A Saracco; S Molinari; N Ziliani; Adriano Lazzarin
Incidence and risk factors of HIV infection: a prospective study of seronegative drug users from Milan and northern Italy, 1987-1989.
Epidemiology (Cambridge, Mass.) 1990;1(6):453-9.
1990: Giuseppe Girasole; J M Wang; Mario Pedrazzoni; G Pioli; Claudia Balotta; M Passeri; Adriano Lazzarin; Anna Lisa Ridolfo; A Mantovani
Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(8):2459-64.
1990: G Finazzi; P M Mannucci; Adriano Lazzarin; A Gringeri; C Arici; D Ciaci; R Terzi; T Barbui
Low incidence of bleeding from HIV-related thrombocytopenia in drug addicts and hemophiliacs: implications for therapeutic strategies.
European journal of haematology 1990;45(2):82-5.
1990: Guido Cavalli; S Lopez; Fabio Franzetti; M C Amprimo; Paolo Ronchi; Paola Cinque; P Rivera; P C Gaido; Adriano Lazzarin
Diagnostic and prognostic significance of beta 2-microglobulin during HIV infection.
La Ricerca in clinica e in laboratorio 1990;20(2):105-11.
1990: Giovanni Rezza; Adriano Lazzarin; G Angarano; R Zerboni; Alessandro Sinicco; Bernardino Salassa; R Pristerà; M Barbanera; L Ortona; Fernando Aiuti
Risk of AIDS in HIV seroconverters: a comparison between intravenous drug users and homosexual males.
European journal of epidemiology 1990;6(1):99-101.
1990: Antonio Miadonna; E Leggieri; Alberto Tedeschi; Adriano Lazzarin; L Chianura; M Froldi; C Zanussi
Enhanced basophil releasability in subjects infected with human immunodeficiency virus.
Clinical immunology and immunopathology 1990;54(2):237-46.
1990: G Ferraro; P L Meroni; Nicoletta Del Papa; Wilma Barcellini; M Orietta Borghi; Adriano Lazzarin; Mauro Moroni; C Zanussi
In vitro modulation of human endothelial cell growth by Kaposi's sarcoma sera.
Journal of acquired immune deficiency syndromes 1990;3(7):677-82.
1990: M Froldi; Adriano Lazzarin; C Zanussi
[The inflammatory process].
Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale 1990;10 Suppl 28():11-21.
1990: Adriano Lazzarin; R Esposito; M T Reale; G Orlando; Mauro Moroni; A Cargnel; Tiziana Quirino; C Arici; A Nicolosi
Epidemiology of toxoplasma encephalitis and need for primary prophylaxis among AIDS patients in northern Italy.
Journal of acquired immune deficiency syndromes 1990;3(11):1114.
1990: G Landonio; Massimo Galli; A Nosari; Adriano Lazzarin; D Cipriani; P Crocchiolo; L Voltolin; F Giannelli; L Irato; Francesco de Cataldo
HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation.
AIDS (London, England) 1990;4(1):29-34.
1989: A Saracco; Adriano Lazzarin; Massimo Musicco; M Moroni
Gender, relationship length and the risk of heterosexual HIV transmission.
European journal of epidemiology 1989;5(3):403-4.
1989: Giovanni Rezza; Adriano Lazzarin; G Angarano; Alessandro Sinicco; R Pristerà; L Ortona; M Barbanera; Bernardino Salassa; U Tirelli; Fernando Aiuti
Risk of developing AIDS in newly seropositive intravenous drug abusers.
The Journal of infectious diseases 1989;159(6):1156.
1989: Antonella d'Arminio Monforte; Roberto Novati; Paola Marchisio; N Zanchetta; Caterina Uberti-Foppa; R Tornaghi; E Massironi; Adriano Lazzarin; Nicola Principi
Early diagnosis of HIV infection in infants.
AIDS (London, England) 1989;3(6):391-5.
1989: Giovanni Rezza; Adriano Lazzarin; G Angarano; Alessandro Sinicco; R Pristerà; L Ortona; M Barbanera; S Gafà; U Tirelli; Bernardino Salassa
The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters.
AIDS (London, England) 1989;3(2):87-90.
1989: Luca Vago; M C Antonacci; S Cristina; Carlo Parravicini; Adriano Lazzarin; Mauro Moroni; C Negri; Caterina Uberti-Foppa; M Musicco; Giulio Costanzi
Morphogenesis, evolution and prognostic significance of lymphatic tissue lesions in HIV infection.
Applied pathology 1989;7(5):298-309.
1989: Massimo Galli; Adriano Lazzarin; A Saracco; Claudia Balotta; Antonella Castagna; C Negri; Anna Lisa Ridolfo; Caterina Uberti-Foppa; Mario Corbellino; Mauro Moroni
Clinical and immunological aspects of HIV infection in drug addicts.
Clinical immunology and immunopathology 1989;50(1 Pt 2):S166-76.
1989: P Crocchiolo; R Pristera; Adriano Lazzarin; M Chemotti; M Froldi; E Palazzini; Paola Verani; A Orecchia; M Moroni
A trial with ribavirin in patients with AIDS or AIDS-related complex.
Bollettino dell'Istituto sieroterapico milanese 1989;68(2):185-90.
1988: Fabio Franzetti; Guido Cavalli; C U Foppa; M C Amprimo; P Gaido; Adriano Lazzarin
Raised serum beta 2 microglobulin levels in different stages of human immunodeficiency virus infection.
Journal of clinical & laboratory immunology 1988;27(3):133-7.
1988: Giorgio Baroldi; S Corallo; Mauro Moroni; Alberto Repossini; M R Mutinelli; Adriano Lazzarin; C M Antonacci; S Cristina; C Negri
Focal lymphocytic myocarditis in acquired immunodeficiency syndrome (AIDS): a correlative morphologic and clinical study in 26 consecutive fatal cases.
Journal of the American College of Cardiology 1988;12(2):463-9.
1988: S Corallo; M R Mutinelli; Mauro Moroni; Adriano Lazzarin; V Celano; Alberto Repossini; Giorgio Baroldi
Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients.
European heart journal 1988;9(8):887-92.
1988: R Scorza Smeraldi; Giovanna Fabio; Adriano Lazzarin; N Eisera; Caterina Uberti-Foppa; M Moroni; C Zanussi
HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts.
Human immunology 1988;22(2):73-9.
1988: Adriano Lazzarin; C Negri; Giuseppe Tambussi; A Saracco; Massimo Galli; P Crocchiolo; L Irato; Antonella Castagna; Mauro Moroni
T-lymphocyte subsets and delayed type hypersensitivity as classification parameters for HIV infection among drug-addicts.
Journal of clinical & laboratory immunology 1988;25(4):157-60.
1988: G Barbiano di Belgiojoso; A Genderini; N Zanchetta; Adriano Lazzarin; S Bertoli
AIDS in dialysis centers: an emerging risk?
Contributions to nephrology 1988;61():254-65.
1987: Fausto Titti; Adriano Lazzarin; Paolo Costigliola; C Oliva; Loredana Nicoletti; C Negri; E Ricchi; G Donati; Caterina Uberti-Foppa; Maria Carla Re
Human immunodeficiency virus (HIV) seropositivity in intravenous (i.v.) drug abusers in three cities of Italy: possible natural history of HIV infection in i.v. drug addicts in Italy.
Journal of medical virology 1987;23(3):241-8.
1987: Mauro Moroni; Adriano Lazzarin; G Orlando; P Crocchiolo; Antonella Castagna; Paola Verani
Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(2 Suppl):639-41.
1987: Adriano Lazzarin; Caterina Uberti-Foppa; C Negri; G Orlando; T Re; Mauro Moroni
Epidemiological aspects of human immunodeficiency virus infection in Milan.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(2 Suppl):632-3.
1987: Caterina Uberti-Foppa; N Zanchetta; Giuseppe Nardi; T Re; G Orlando; Paola Cinque; Adriano Lazzarin
Risk of HIV infection in recipients of blood and blood products.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(2 Suppl):633-4.
1987: S Procaccia; Adriano Lazzarin; A Colucci; A Gasparini; P Forcellini; D Lanzanova; C U Foppa; Roberto Novati; C Zanussi
IgM, IgG and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities.
Clinical and experimental immunology 1987;67(2):236-44.
1987: Caterina Uberti-Foppa; Fabio Franzetti; C Negri; Roberto Novati; Paola Cinque; G Privitera; F Parente; P Crocchiolo; Adriano Lazzarin
Role of PMN's candidicidal activity in the pathogenesis of AIDS-related systemic candidiases.
Bollettino dell'Istituto sieroterapico milanese 1987;66(6):471-8.
1987: G B Rossi; Paola Verani; Beatrice Macchi; Maurizio Federico; A Orecchia; Loredana Nicoletti; Stefano Buttò; Adriano Lazzarin; G Mariani; G Ippolito
Recovery of HIV-related retroviruses from Italian patients with AIDS or AIDS-related complex and from asymptomatic at-risk individuals.
Annals of the New York Academy of Sciences 1987;511():390-400.
1987: M Luerti; Adriano Lazzarin; E Corbella; G Zavattini
An alternative to steroids for prevention of respiratory distress syndrome (RDS): multicenter controlled study to compare ambroxol and betamethasone.
Journal of perinatal medicine 1987;15(3):227-38.
1987: Adriano Lazzarin; Wilma Barcellini; Caterina Uberti-Foppa; Maria Orietta Borghi; R Franzetti; Paola Cinque; Mauro Moroni
Experiences with immunomodulant agents in HIV infections.
Acta haematologica 1987;78 Suppl 1():84-90.
1986: R Scorza Smeraldi; Giovanna Fabio; Adriano Lazzarin; N B Eisera; M Moroni; C Zanussi
HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection.
Lancet 1986;2(8517):1187-9.
1986: Adriano Lazzarin; M Luerti; Franco Capsoni; M Galli; Caterina Uberti-Foppa; G Zavattini; E Corbella
A study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS).
International journal of tissue reactions 1986;8(2):157-65.
1986: Adriano Lazzarin; G Orlando; G Privitera; P Crocchiolo; R Esposito; Caterina Uberti-Foppa; Antonella Castagna; L Irato; Mauro Moroni
Clinical and epidemiological aspects of the first 50 cases of AIDS in Milan.
Bollettino dell'Istituto sieroterapico milanese 1986;65(6):481-6.
1985: Massimo Galli; P Crocchiolo; C Negri; F Caredda; Adriano Lazzarin; Mauro Moroni
Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results.
Drugs under experimental and clinical research 1985;11(9):665-9.
1985: Franco Capsoni; Anna Maria Ongari; Francesca Minonzio; Adriano Lazzarin; G Zavattini
Effect of ambroxol on human phagocytic cell function.
Bollettino dell'Istituto sieroterapico milanese 1985;64(3):236-9.
1984: Franco Capsoni; Adriano Lazzarin; M Vezzio; Anna Maria Ongari; W Uberti-Foppa; G Zavattini
[Effect of ambroxol on the activity of phagocytic cells in vitro].
Archivio Monaldi per la tisiologia e le malattie dell'apparato respiratorio 1984;39(3):235-9.
1984: Adriano Lazzarin; M Luerti; Caterina Uberti-Foppa; G Zavattini; A Rossi; R Tornaghi
Polymorphonuclear leucocytes functions from premature infants after prevention of respiratory distress syndrome with betamethasone and ambroxol.
Biological research in pregnancy and perinatology 1984;5(3):130-4.
1984: G Del Giudice; Massimo Galli; M Chemotti; M Gasparro; F Franzetti; Adriano Lazzarin
Brachial paresis complicating acute non-A, non-B hepatitis.
Bollettino dell'Istituto sieroterapico milanese 1984;63(6):499-504.